Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV3-64D IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	1.17e-13	190	236	20	GO:0003823
GeneOntologyMolecularFunction	cytoskeletal protein binding	HIP1 LARP6 MYO1A MYO7B TTLL5 LRRK2 NEB MYO3A ALMS1 CCR5 HOOK2 YWHAQ MYO18B BIN1 NRAP SYNE1 KIF21A CEP290 NUMA1 FSD1 BLOC1S2 YWHAH LRPPRC MICALL2 LMO7 DNM3 CDK5RAP2 DAAM1 CEP57	4.39e-05	1099	236	29	GO:0008092
GeneOntologyMolecularFunction	actin filament binding	HIP1 MYO1A MYO7B NEB MYO3A MYO18B BIN1 NRAP SYNE1 LRPPRC MICALL2	8.60e-05	227	236	11	GO:0051015
GeneOntologyMolecularFunction	sulfonylurea receptor activity	ABCC8 ABCC9	1.39e-04	2	236	2	GO:0008281
GeneOntologyMolecularFunction	phosphatidylinositol kinase activity	PIK3C2A PIK3C2B PIK3C3 PI4KA	2.32e-04	26	236	4	GO:0052742
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-kinase activity	PIK3C2A PIK3C2B PIK3C3	2.51e-04	11	236	3	GO:0016303
GeneOntologyMolecularFunction	microtubule binding	LRRK2 ALMS1 HOOK2 YWHAQ KIF21A CEP290 NUMA1 FSD1 LRPPRC DNM3 CDK5RAP2 CEP57	3.19e-04	308	236	12	GO:0008017
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	4.14e-04	3	236	2	GO:0035979
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1A MYO7B MYO3A MYO18B DNAH9 DYNC2H1 KIF21A	5.11e-04	118	236	7	GO:0003774
GeneOntologyMolecularFunction	tubulin binding	TTLL5 LRRK2 ALMS1 HOOK2 YWHAQ KIF21A CEP290 NUMA1 FSD1 BLOC1S2 LRPPRC DNM3 CDK5RAP2 CEP57	6.04e-04	428	236	14	GO:0015631
GeneOntologyMolecularFunction	actin binding	HIP1 MYO1A MYO7B LRRK2 NEB MYO3A CCR5 MYO18B BIN1 NRAP SYNE1 YWHAH LRPPRC MICALL2 DAAM1	6.09e-04	479	236	15	GO:0003779
GeneOntologyMolecularFunction	gamma-tubulin binding	YWHAQ BLOC1S2 CDK5RAP2 CEP57	1.02e-03	38	236	4	GO:0043015
GeneOntologyMolecularFunction	transmembrane transporter binding	TRPC1 LRRK2 ABCC8 YWHAQ ABCC9 YWHAH YWHAZ AKAP9	1.04e-03	172	236	8	GO:0044325
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV3-64D IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	3.54e-12	235	236	20	GO:0016064
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV3-64D IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	7.08e-12	244	236	20	GO:0019724
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IGHV3-64D FBXO38 IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 LAMP1 IGHV3-43D IGHV3-30-3	1.16e-08	449	236	22	GO:0002449
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 VPS54 KRT23	1.81e-08	99	236	11	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 VPS54 KRT23	2.02e-08	100	236	11	GO:0045103
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV3-64D FBXO38 IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	9.05e-08	462	236	21	GO:0002460
GeneOntologyBiologicalProcess	organelle localization	MYO1A LRRK2 FAM91A1 FYCO1 CHMP7 VPS33B ASPM TERB1 YWHAQ BIN1 RB1 SYNE1 CEP290 NUMA1 LAMP1 BLOC1S2 YWHAZ MADD LRPPRC AKAP9 MEIOC TRAPPC12 DNM3 CDK5RAP2 ZW10 GPSM1	1.54e-07	703	236	26	GO:0051640
GeneOntologyBiologicalProcess	intermediate filament organization	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT34 KRT23	1.88e-07	75	236	9	GO:0045109
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IGHV3-64D FBXO38 IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 LAMP1 YWHAZ IGHV3-43D IGHV3-30-3	2.21e-07	576	236	23	GO:0002443
GeneOntologyBiologicalProcess	microtubule-based process	TTC21A TTLL5 DRC1 FYCO1 CHMP7 ALMS1 ASPM HOOK2 YWHAQ DNAH9 IQCG DYNC2H1 KIF21A CEP290 NUMA1 APBA1 LAMP1 FSD1 BLOC1S2 MADD LRPPRC C2CD3 AKAP9 GCC2 CENPH RNASE10 TTC21B CFAP58 CDK5RAP2 ZW10 GPSM1 PCNT	5.04e-07	1058	236	32	GO:0007017
GeneOntologyBiologicalProcess	establishment of organelle localization	LRRK2 FAM91A1 FYCO1 CHMP7 TERB1 YWHAQ RB1 SYNE1 NUMA1 LAMP1 BLOC1S2 YWHAZ MADD LRPPRC MEIOC TRAPPC12 DNM3 CDK5RAP2 ZW10 GPSM1	5.20e-06	546	236	20	GO:0051656
GeneOntologyBiologicalProcess	supramolecular fiber organization	HIP1 MYO1A MYO7B KRT27 NEB ALMS1 VPS33B HOOK2 YWHAQ KRT25 KRT7 KRT9 BIN1 KRT12 KRT13 KRT14 NRAP RB1 KRT34 NUMA1 FSD1 CYFIP2 KRT23 AKAP9 MICALL2 ELMO2 CDK5RAP2 NOSTRIN	5.21e-06	957	236	28	GO:0097435
GeneOntologyBiologicalProcess	immune effector process	IGHV3-64D FBXO38 IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 DOCK2 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 LAMP1 TEK YWHAZ IGHV3-43D IGHV3-30-3 PRKDC	6.39e-06	859	236	26	GO:0002252
GeneOntologyBiologicalProcess	intracellular transport	TTC21A LRRK2 FAM91A1 FYCO1 NSUN2 CHMP7 SMG7 ALMS1 AP2A2 VPS33B PIK3C3 HOOK2 ABCD2 NXF1 BIN1 DYNC2H1 SYNE1 CEP290 VPS8 NUMA1 APBA1 LAMP1 VPS54 MED1 TEK BLOC1S2 YWHAH MADD LRPPRC NUP155 MICALL2 TRAPPC12 GCC2 TTC21B CACNG5 ZW10 PCNT	7.21e-06	1496	236	37	GO:0046907
GeneOntologyBiologicalProcess	lysosomal transport	LRRK2 CHMP7 VPS33B PIK3C3 HOOK2 BIN1 LAMP1 VPS54 GCC2 CACNG5	9.74e-06	151	236	10	GO:0007041
GeneOntologyBiologicalProcess	endomembrane system organization	ATR LRRK2 CHMP7 VPS33B PIK3C3 HACE1 HOOK2 ABCD2 TRIM72 CACNA1B BIN1 DYNC2H1 SYNE1 UBR4 BLOC1S2 YWHAZ AKAP9 NUP155 TRAPPC12 GCC2 RIMBP2 ZW10	1.03e-05	672	236	22	GO:0010256
GeneOntologyBiologicalProcess	vacuolar transport	LRRK2 CHMP7 VPS33B PIK3C3 HOOK2 BIN1 VPS8 LAMP1 VPS54 GCC2 CACNG5	1.08e-05	187	236	11	GO:0007034
GeneOntologyBiologicalProcess	spermatogenesis	TTC21A TTLL5 LRRK2 LGR4 DRC1 USP9Y NSUN2 ALMS1 ASPM IQCG KRT9 RB1 SYNE1 CIP2A LAMP1 VPS54 TDRD1 DMC1 AKAP9 MEIOC CFAP58 CEP57	4.84e-05	744	236	22	GO:0007283
GeneOntologyBiologicalProcess	nuclear chromosome segregation	NCAPH2 CHMP7 ANAPC1 ANAPC2 ASPM TERB1 YWHAQ RB1 NUMA1 DMC1 MEIOC TRAPPC12 CDK5RAP2 ZW10	6.59e-05	356	236	14	GO:0098813
GeneOntologyBiologicalProcess	male gamete generation	TTC21A TTLL5 LRRK2 LGR4 DRC1 USP9Y NSUN2 ALMS1 ASPM IQCG KRT9 RB1 SYNE1 CIP2A LAMP1 VPS54 TDRD1 DMC1 AKAP9 MEIOC CFAP58 CEP57	6.87e-05	762	236	22	GO:0048232
GeneOntologyBiologicalProcess	establishment of mitotic spindle orientation	YWHAQ NUMA1 CDK5RAP2 ZW10 GPSM1	7.88e-05	39	236	5	GO:0000132
GeneOntologyBiologicalProcess	sexual reproduction	ZNF148 TTC21A TTLL5 LRRK2 LGR4 DRC1 NCAPH2 USP9Y NSUN2 ALMS1 ANAPC1 ANAPC2 ASPM TERB1 IQCG KRT9 RB1 PRAMEF19 SYNE1 CIP2A NUMA1 LAMP1 VPS54 TDRD1 DMC1 AKAP9 MEIOC RNASE10 CFAP58 ZW10 CEP57	1.01e-04	1312	236	31	GO:0019953
GeneOntologyBiologicalProcess	spindle localization	ASPM YWHAQ NUMA1 CDK5RAP2 ZW10 GPSM1	1.17e-04	67	236	6	GO:0051653
GeneOntologyBiologicalProcess	Golgi organization	LRRK2 HACE1 DYNC2H1 SYNE1 YWHAZ AKAP9 TRAPPC12 GCC2 ZW10	1.41e-04	168	236	9	GO:0007030
GeneOntologyBiologicalProcess	establishment of mitotic spindle localization	YWHAQ NUMA1 CDK5RAP2 ZW10 GPSM1	1.42e-04	44	236	5	GO:0040001
GeneOntologyBiologicalProcess	phosphatidylinositol-mediated signaling	PIK3C2A PIK3C2B PIK3C3 PI4KA	1.48e-04	24	236	4	GO:0048015
GeneOntologyBiologicalProcess	cardiac conduction	TRPC1 RYR2 BIN1 ABCC9 TNNI3K AKAP9 NUP155	1.52e-04	100	236	7	GO:0061337
GeneOntologyBiologicalProcess	gamete generation	ZNF148 TTC21A TTLL5 LRRK2 LGR4 DRC1 NCAPH2 USP9Y NSUN2 ALMS1 ASPM IQCG KRT9 RB1 PRAMEF19 SYNE1 CIP2A LAMP1 VPS54 TDRD1 DMC1 AKAP9 MEIOC CFAP58 CEP57	1.61e-04	982	236	25	GO:0007276
GeneOntologyBiologicalProcess	establishment of spindle orientation	YWHAQ NUMA1 CDK5RAP2 ZW10 GPSM1	1.76e-04	46	236	5	GO:0051294
GeneOntologyBiologicalProcess	regulation of neuron differentiation	LRRK2 ASPM CCR5 YWHAQ BIN1 HES3 MED1 TFAP2A YWHAG YWHAH CDK5RAP2	1.81e-04	255	236	11	GO:0045664
GeneOntologyBiologicalProcess	microtubule-based movement	TTC21A TTLL5 DRC1 FYCO1 DNAH9 IQCG DYNC2H1 KIF21A APBA1 LAMP1 BLOC1S2 MADD LRPPRC RNASE10 TTC21B CFAP58	1.90e-04	493	236	16	GO:0007018
GeneOntologyBiologicalProcess	regulation of chromosome segregation	NCAPH2 ANAPC1 ANAPC2 YWHAQ RB1 NUMA1 CDK5RAP2 ZW10	2.03e-04	139	236	8	GO:0051983
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	TTLL5 DRC1 CHMP7 ALMS1 ASPM HOOK2 YWHAQ IQCG CEP290 NUMA1 FSD1 C2CD3 AKAP9 GCC2 CENPH CFAP58 CDK5RAP2 ZW10 GPSM1 PCNT	2.46e-04	720	236	20	GO:0000226
GeneOntologyBiologicalProcess	adaptive immune response	IGHV3-64D FBXO38 ERAP2 IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	2.65e-04	838	236	22	GO:0002250
GeneOntologyBiologicalProcess	organelle assembly	TTLL5 LRRK2 DRC1 NEB CHMP7 ALMS1 VPS33B PIK3C3 SURF6 ASPM YWHAQ IQCG NRAP TBC1D30 DYNC2H1 SYNE1 CEP290 ATG2B NUMA1 C2CD3 TRAPPC12 CENPH TTC21B CFAP58 CDK5RAP2 PRKDC PCNT	2.73e-04	1138	236	27	GO:0070925
GeneOntologyBiologicalProcess	cytoskeleton-dependent intracellular transport	TTC21A FYCO1 HOOK2 DYNC2H1 APBA1 LAMP1 BLOC1S2 MADD LRPPRC TTC21B	2.79e-04	225	236	10	GO:0030705
GeneOntologyBiologicalProcess	regulation of sister chromatid segregation	ANAPC1 ANAPC2 YWHAQ RB1 NUMA1 CDK5RAP2 ZW10	2.91e-04	111	236	7	GO:0033045
GeneOntologyBiologicalProcess	regulation of chromosome separation	NCAPH2 YWHAQ RB1 NUMA1 CDK5RAP2 ZW10	2.92e-04	79	236	6	GO:1905818
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization involved in mitosis	CHMP7 YWHAQ NUMA1 FSD1 CENPH CDK5RAP2 ZW10 GPSM1 PCNT	3.14e-04	187	236	9	GO:1902850
GeneOntologyBiologicalProcess	spermatid differentiation	TTC21A TTLL5 DRC1 NSUN2 ALMS1 IQCG VPS54 DMC1 MEIOC CFAP58 CEP57	3.15e-04	272	236	11	GO:0048515
GeneOntologyBiologicalProcess	chromosome segregation	NCAPH2 CHMP7 ANAPC1 ANAPC2 ASPM TERB1 YWHAQ RB1 NUMA1 DMC1 MEIOC TRAPPC12 CENPH CDK5RAP2 ZW10	3.20e-04	465	236	15	GO:0007059
GeneOntologyBiologicalProcess	cell projection assembly	RAPGEF6 MYO1A TTLL5 DRC1 TENM2 MYO3A ALMS1 FGD5 IQCG TBC1D30 DYNC2H1 SYNE1 CEP290 CYFIP2 C2CD3 TTC21B CFAP58 DNM3 PCNT	3.58e-04	685	236	19	GO:0030031
GeneOntologyBiologicalProcess	chromosome organization	ATR NCAPH2 CHMP7 ANAPC1 ANAPC2 TERB1 YWHAQ RB1 CIP2A NUMA1 RFC1 DMC1 NUP155 MEIOC TRAPPC12 CENPH CDK5RAP2 PRKDC ZW10	3.65e-04	686	236	19	GO:0051276
GeneOntologyBiologicalProcess	cardiac muscle thin filament assembly	NEB NRAP	3.88e-04	3	236	2	GO:0071691
GeneOntologyBiologicalProcess	synaptic target recognition	SEMA3A YWHAZ	3.88e-04	3	236	2	GO:0008039
GeneOntologyBiologicalProcess	transport along microtubule	TTC21A FYCO1 DYNC2H1 APBA1 LAMP1 BLOC1S2 MADD LRPPRC TTC21B	4.59e-04	197	236	9	GO:0010970
GeneOntologyBiologicalProcess	establishment of chromosome localization	CHMP7 TERB1 RB1 NUMA1 MEIOC TRAPPC12 ZW10	5.16e-04	122	236	7	GO:0051303
GeneOntologyBiologicalProcess	chromosome separation	NCAPH2 YWHAQ RB1 NUMA1 CDK5RAP2 ZW10	5.22e-04	88	236	6	GO:0051304
GeneOntologyBiologicalProcess	neurotransmitter receptor internalization	HIP1 AP2A2 SYNE1 DNM3 CACNG5	5.26e-04	58	236	5	GO:0099590
GeneOntologyBiologicalProcess	regulation of microtubule-based process	DRC1 CHMP7 ALMS1 YWHAQ NUMA1 LAMP1 FSD1 AKAP9 RNASE10 TTC21B CDK5RAP2	5.87e-04	293	236	11	GO:0032886
GeneOntologyBiologicalProcess	intraciliary retrograde transport	TTC21A DYNC2H1 TTC21B	6.08e-04	15	236	3	GO:0035721
GeneOntologyBiologicalProcess	vacuole organization	LRRK2 CHMP7 VPS33B PIK3C2A PIK3C2B PIK3C3 HOOK2 ATG2B LAMP1 VPS54	6.19e-04	249	236	10	GO:0007033
GeneOntologyBiologicalProcess	microtubule-based transport	TTC21A FYCO1 DNAH9 DYNC2H1 APBA1 LAMP1 BLOC1S2 MADD LRPPRC TTC21B	7.00e-04	253	236	10	GO:0099111
GeneOntologyBiologicalProcess	epithelium development	RAPGEF6 KRT27 LAMA1 LGR4 NSUN2 RYR2 SEMA3A MYO3A CCM2 ALMS1 PTPRQ KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT34 CEP290 NUMA1 HES3 MED1 TEK TFAP2A KRT23 C2CD3 AKAP9 RNASE10 PRKDC PAX7 PCNT	7.12e-04	1469	236	31	GO:0060429
GeneOntologyBiologicalProcess	establishment of spindle localization	YWHAQ NUMA1 CDK5RAP2 ZW10 GPSM1	7.15e-04	62	236	5	GO:0051293
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	RAPGEF6 MYO1A TTLL5 DRC1 TENM2 MYO3A ALMS1 FGD5 IQCG TBC1D30 DYNC2H1 SYNE1 CEP290 C2CD3 TTC21B CFAP58 DNM3 PCNT	7.40e-04	670	236	18	GO:0120031
GeneOntologyBiologicalProcess	chromosome localization	CHMP7 TERB1 RB1 NUMA1 MEIOC TRAPPC12 ZW10	7.54e-04	130	236	7	GO:0050000
GeneOntologyBiologicalProcess	protein localization to organelle	ATR TTC21A LRRK2 RYR2 CHMP7 PIK3C3 RB1 DYNC2H1 SYNE1 VPS8 NUMA1 LAMP1 VPS54 MED1 TEK YWHAZ C2CD3 NUP155 MICALL2 TRAPPC12 GCC2 TTC21B CFAP58 CACNG5 ZW10	7.66e-04	1091	236	25	GO:0033365
GeneOntologyBiologicalProcess	positive regulation of microtubule polymerization	YWHAQ NUMA1 AKAP9 CDK5RAP2	8.20e-04	37	236	4	GO:0031116
GeneOntologyBiologicalProcess	synaptic vesicle endocytosis	ABCA13 LRRK2 AP2A2 PIK3C3 BIN1 DNM3	8.28e-04	96	236	6	GO:0048488
GeneOntologyCellularComponent	immunoglobulin complex	IGHV3-64D IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	3.40e-15	166	235	20	GO:0019814
GeneOntologyCellularComponent	supramolecular fiber	IGFN1 MYO1A KRT27 TRPC1 TTLL5 NEB RYR2 CHMP7 MYO3A ASPM HOOK2 YWHAQ MYO18B DNAH9 KRT25 KRT7 KRT9 BIN1 KRT12 KRT13 KRT14 NRAP KRT18 DYNC2H1 KRT34 SYNE1 KIF21A NUMA1 ABCC9 FSD1 TEK KRT23 LRPPRC UNC45B DNM3 CDK5RAP2 DCTN4 ZW10 CEP57 PCNT	3.47e-10	1179	235	40	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	IGFN1 MYO1A KRT27 TRPC1 TTLL5 NEB RYR2 CHMP7 MYO3A ASPM HOOK2 YWHAQ MYO18B DNAH9 KRT25 KRT7 KRT9 BIN1 KRT12 KRT13 KRT14 NRAP KRT18 DYNC2H1 KRT34 SYNE1 KIF21A NUMA1 ABCC9 FSD1 TEK KRT23 LRPPRC UNC45B DNM3 CDK5RAP2 DCTN4 ZW10 CEP57 PCNT	4.23e-10	1187	235	40	GO:0099081
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	MYO1A KRT27 TTLL5 CHMP7 MYO3A ASPM HOOK2 YWHAQ MYO18B DNAH9 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 DYNC2H1 KRT34 KIF21A NUMA1 FSD1 TEK KRT23 LRPPRC DNM3 CDK5RAP2 ZW10 CEP57 PCNT	1.03e-07	899	235	30	GO:0099513
GeneOntologyCellularComponent	centrosome	RAPGEF6 TTLL5 HMMR SFR1 HNMT ALMS1 ASPM HOOK2 YWHAQ KRT18 UBR4 CEP290 NUMA1 ANKRD62 FSD1 TEK BLOC1S2 C2CD3 AKAP9 CFAP58 CDK5RAP2 DCTN4 CEP57 PCNT	6.82e-06	770	235	24	GO:0005813
GeneOntologyCellularComponent	microtubule organizing center	RAPGEF6 TTLL5 HMMR SFR1 HNMT ALMS1 ASPM HOOK2 YWHAQ TBC1D30 KRT18 UBR4 CEP290 NUMA1 ANKRD62 FSD1 TEK BLOC1S2 C2CD3 AKAP9 CFAP58 CDK5RAP2 DAAM1 DCTN4 CEP57 PCNT	1.53e-05	919	235	26	GO:0005815
GeneOntologyCellularComponent	sarcomere	IGFN1 TRPC1 NEB RYR2 MYO18B BIN1 NRAP SYNE1 ABCC9 UNC45B DCTN4	1.26e-04	249	235	11	GO:0030017
GeneOntologyCellularComponent	vesicle tethering complex	VPS33B HOOK2 VPS8 VPS54 TRAPPC12 ZW10	1.59e-04	72	235	6	GO:0099023
GeneOntologyCellularComponent	intermediate filament cytoskeleton	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23 PADI6	2.03e-04	263	235	11	GO:0045111
GeneOntologyCellularComponent	pericentriolar material	YWHAQ AKAP9 CDK5RAP2 PCNT	2.58e-04	28	235	4	GO:0000242
GeneOntologyCellularComponent	intermediate filament	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	2.61e-04	227	235	10	GO:0005882
GeneOntologyCellularComponent	myofibril	IGFN1 TRPC1 NEB RYR2 MYO18B BIN1 NRAP SYNE1 ABCC9 UNC45B DCTN4	2.80e-04	273	235	11	GO:0030016
GeneOntologyCellularComponent	microtubule	TTLL5 CHMP7 ASPM HOOK2 YWHAQ DNAH9 DYNC2H1 KIF21A NUMA1 FSD1 LRPPRC DNM3 CDK5RAP2 ZW10 CEP57 PCNT	3.71e-04	533	235	16	GO:0005874
GeneOntologyCellularComponent	potassium ion-transporting ATPase complex	ABCC8 ABCC9	3.75e-04	3	235	2	GO:0031004
GeneOntologyCellularComponent	HOPS complex	VPS33B HOOK2 VPS8	4.66e-04	14	235	3	GO:0030897
GeneOntologyCellularComponent	contractile muscle fiber	IGFN1 TRPC1 NEB RYR2 MYO18B BIN1 NRAP SYNE1 ABCC9 UNC45B DCTN4	4.66e-04	290	235	11	GO:0043292
GeneOntologyCellularComponent	inward rectifying potassium channel	ABCC8 ABCC9	7.44e-04	4	235	2	GO:0008282
GeneOntologyCellularComponent	keratin filament	KRT25 KRT7 KRT9 KRT13 KRT14 KRT18	7.98e-04	97	235	6	GO:0045095
GeneOntologyCellularComponent	microtubule end	ASPM YWHAQ NUMA1 CDK5RAP2	8.51e-04	38	235	4	GO:1990752
GeneOntologyCellularComponent	autolysosome	LRRK2 PIK3C3 LAMP1	1.01e-03	18	235	3	GO:0044754
GeneOntologyCellularComponent	extrinsic component of membrane	ATR TENM2 RYR2 PIK3C2A PIK3C2B PIK3C3 BIN1 CNKSR2 AKAP9	1.22e-03	230	235	9	GO:0019898
GeneOntologyCellularComponent	actin-based cell projection	MYO1A MYO7B LRRK2 TENM2 MYO3A CLCA1 PTPRQ CALB2 TEK IGF2BP1	1.25e-03	278	235	10	GO:0098858
GeneOntologyCellularComponent	mitotic spindle pole	ASPM YWHAQ NUMA1 CDK5RAP2	1.36e-03	43	235	4	GO:0097431
GeneOntologyCellularComponent	gamma-tubulin complex	YWHAQ BLOC1S2 CDK5RAP2	1.61e-03	21	235	3	GO:0000930
GeneOntologyCellularComponent	Z disc	IGFN1 NEB RYR2 MYO18B BIN1 NRAP UNC45B	1.63e-03	151	235	7	GO:0030018
GeneOntologyCellularComponent	ciliary basal body	TTLL5 ALMS1 TBC1D30 CEP290 C2CD3 AKAP9 DAAM1 PCNT	1.68e-03	195	235	8	GO:0036064
GeneOntologyCellularComponent	extrinsic component of postsynaptic membrane	TENM2 CNKSR2 AKAP9	1.84e-03	22	235	3	GO:0098890
GeneOntologyCellularComponent	synaptic vesicle	ATR LRRK2 AP2A2 VPS33B ABCC8 BIN1 NPY1R APBA1 LAMP1 MADD	2.19e-03	300	235	10	GO:0008021
GeneOntologyCellularComponent	CORVET complex	VPS33B VPS8	2.55e-03	7	235	2	GO:0033263
GeneOntologyCellularComponent	microtubule minus-end	ASPM NUMA1	2.55e-03	7	235	2	GO:0036449
GeneOntologyCellularComponent	spindle	HMMR NSUN2 CHMP7 ALMS1 ASPM TADA2A YWHAQ RB1 NUMA1 CDK5RAP2 DCTN4 ZW10 PHLPP2	2.72e-03	471	235	13	GO:0005819
GeneOntologyCellularComponent	I band	IGFN1 NEB RYR2 MYO18B BIN1 NRAP UNC45B	2.78e-03	166	235	7	GO:0031674
Domain	ARM-type_fold	RALGAPA1 HIP1 ATR LRRK2 USP9Y AP2A2 PIK3C2A PIK3C2B PIK3C3 PI4KA ASPM TERB1 ZER1 DOCK2 CIP2A MROH2A UBR4 FRYL UNC45B ELMO2 LTN1 PRKDC DAAM1	1.12e-11	339	217	23	IPR016024
Domain	Keratin_I	KRT27 KRT25 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.63e-09	44	217	9	IPR002957
Domain	IF	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.04e-08	72	217	10	PS00226
Domain	PI3/4_kinase_CS	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	1.05e-08	15	217	6	IPR018936
Domain	Filament	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.20e-08	73	217	10	PF00038
Domain	-	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	1.67e-08	16	217	6	1.10.1070.11
Domain	PI3Kc	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	1.67e-08	16	217	6	SM00146
Domain	IF	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.78e-08	76	217	10	IPR001664
Domain	PI3_PI4_kinase	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	3.79e-08	18	217	6	PF00454
Domain	PI3_4_KINASE_1	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	3.79e-08	18	217	6	PS00915
Domain	PI3_4_KINASE_2	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	3.79e-08	18	217	6	PS00916
Domain	PI3/4_kinase_cat_dom	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	3.79e-08	18	217	6	IPR000403
Domain	PI3_4_KINASE_3	ATR PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	3.79e-08	18	217	6	PS50290
Domain	ARM-like	ATR LRRK2 USP9Y AP2A2 ASPM TERB1 ZER1 DOCK2 CIP2A MROH2A FRYL UNC45B ELMO2 LTN1 PRKDC DAAM1	1.14e-07	270	217	16	IPR011989
Domain	Filament	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT23	1.30e-07	71	217	9	SM01391
Domain	14_3_3	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	SM00101
Domain	1433_1	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	PS00796
Domain	1433_2	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	PS00797
Domain	14-3-3_domain	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	IPR023410
Domain	14-3-3_CS	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	IPR023409
Domain	14-3-3	YWHAQ YWHAG YWHAH YWHAZ	6.04e-07	7	217	4	PF00244
Domain	Intermediate_filament_CS	KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	6.53e-07	63	217	8	IPR018039
Domain	14-3-3	YWHAQ YWHAG YWHAH YWHAZ	1.20e-06	8	217	4	IPR000308
Domain	PI3Ka	PIK3C2A PIK3C2B PIK3C3 PI4KA	2.13e-06	9	217	4	PF00613
Domain	PI3Ka	PIK3C2A PIK3C2B PIK3C3 PI4KA	2.13e-06	9	217	4	SM00145
Domain	-	PIK3C2A PIK3C2B PIK3C3 PI4KA	2.13e-06	9	217	4	1.25.40.70
Domain	PI_Kinase	PIK3C2A PIK3C2B PIK3C3 PI4KA	3.52e-06	10	217	4	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2A PIK3C2B PIK3C3 PI4KA	3.52e-06	10	217	4	IPR001263
Domain	PIK_HELICAL	PIK3C2A PIK3C2B PIK3C3 PI4KA	3.52e-06	10	217	4	PS51545
Domain	-	ATR LRRK2 AP2A2 ASPM TERB1 ZER1 CIP2A FRYL UNC45B ELMO2 PRKDC DAAM1	1.16e-05	222	217	12	1.25.10.10
Domain	TPR-like_helical_dom	ATR TTC21A COPS2 SMG7 PRMT9 LRPPRC TRAPPC12 UNC45B TTC21B CSTF3 PRKDC GPSM1	1.89e-05	233	217	12	IPR011990
Domain	-	ATR TTC21A COPS2 SMG7 PRMT9 LRPPRC TRAPPC12 UNC45B TTC21B CSTF3 GPSM1	3.16e-05	207	217	11	1.25.40.10
Domain	PI3K_C2	PIK3C2A PIK3C2B PIK3C3	8.30e-05	8	217	3	SM00142
Domain	PI3K_C2_dom	PIK3C2A PIK3C2B PIK3C3	8.30e-05	8	217	3	IPR002420
Domain	PI3K_C2	PIK3C2A PIK3C2B PIK3C3	8.30e-05	8	217	3	PF00792
Domain	PI3K_C2	PIK3C2A PIK3C2B PIK3C3	8.30e-05	8	217	3	PS51547
Domain	PACT_coil_coil	AKAP9 PCNT	1.34e-04	2	217	2	PF10495
Domain	Sulphorea_rcpt	ABCC8 ABCC9	1.34e-04	2	217	2	IPR000388
Domain	PACT_domain	AKAP9 PCNT	1.34e-04	2	217	2	IPR019528
Domain	IQ	MYO1A MYO7B MYO3A ASPM MYO18B IQCG	1.75e-04	71	217	6	PF00612
Domain	AAA	ABCA13 ABCC8 ABCD2 DNAH9 DYNC2H1 ABCC9 RFC1 DMC1	2.84e-04	144	217	8	SM00382
Domain	AAA+_ATPase	ABCA13 ABCC8 ABCD2 DNAH9 DYNC2H1 ABCC9 RFC1 DMC1	2.84e-04	144	217	8	IPR003593
Domain	-	DAB2IP WWC2 PIK3C2A PIK3C2B PIK3C3 RASAL2 RGS3 C2CD3	3.42e-04	148	217	8	2.60.40.150
Domain	IQ	MYO1A MYO7B MYO3A ASPM MYO18B IQCG	3.61e-04	81	217	6	SM00015
Domain	TPR-contain_dom	TTC21A SMG7 PRMT9 TRAPPC12 UNC45B TTC21B PRKDC GPSM1	3.74e-04	150	217	8	IPR013026
Domain	DUF3498	DAB2IP RASAL2	4.00e-04	3	217	2	IPR021887
Domain	DUF3498	DAB2IP RASAL2	4.00e-04	3	217	2	PF12004
Domain	IQ_motif_EF-hand-BS	MYO1A MYO7B MYO3A ASPM MYO18B IQCG	6.35e-04	90	217	6	IPR000048
Domain	C2_dom	DAB2IP WWC2 PIK3C2A PIK3C2B PIK3C3 RASAL2 RGS3 C2CD3	6.77e-04	164	217	8	IPR000008
Domain	TPR_REGION	TTC21A SMG7 PRMT9 TRAPPC12 UNC45B TTC21B PRKDC GPSM1	7.04e-04	165	217	8	PS50293
Domain	TPR	TTC21A SMG7 PRMT9 TRAPPC12 UNC45B TTC21B PRKDC GPSM1	7.04e-04	165	217	8	PS50005
Domain	IQ	MYO1A MYO7B MYO3A ASPM MYO18B IQCG	7.55e-04	93	217	6	PS50096
Domain	Nebulin	NEB NRAP	7.94e-04	4	217	2	PF00880
Domain	NEBULIN	NEB NRAP	7.94e-04	4	217	2	PS51216
Domain	NEBU	NEB NRAP	7.94e-04	4	217	2	SM00227
Domain	Nebulin	NEB NRAP	7.94e-04	4	217	2	IPR013998
Domain	Nebulin_repeat	NEB NRAP	7.94e-04	4	217	2	IPR000900
Domain	CH	ASPM LRCH2 SYNE1 MICALL2 LMO7	9.48e-04	65	217	5	SM00033
Domain	Myosin_head_motor_dom	MYO1A MYO7B MYO3A MYO18B	9.60e-04	38	217	4	IPR001609
Domain	MYOSIN_MOTOR	MYO1A MYO7B MYO3A MYO18B	9.60e-04	38	217	4	PS51456
Domain	Myosin_head	MYO1A MYO7B MYO3A MYO18B	9.60e-04	38	217	4	PF00063
Domain	MYSc	MYO1A MYO7B MYO3A MYO18B	9.60e-04	38	217	4	SM00242
Domain	C2	DAB2IP PIK3C2A PIK3C2B PIK3C3 RASAL2 RGS3 C2CD3	1.11e-03	137	217	7	SM00239
Domain	FATC	ATR PRKDC	1.31e-03	5	217	2	PF02260
Domain	CH	ASPM LRCH2 SYNE1 MICALL2 LMO7	1.33e-03	70	217	5	PF00307
Domain	C2	DAB2IP WWC2 PIK3C2A PIK3C2B RASAL2 RGS3 C2CD3	1.37e-03	142	217	7	PS50004
Domain	-	LRRK2 LGR4 FBXO38 ZER1 NXF1 LRCH2 PRAMEF19 TLR10 LGI2 LRRC28 PHLPP2	1.38e-03	321	217	11	3.80.10.10
Domain	-	ASPM LRCH2 SYNE1 MICALL2 LMO7	1.41e-03	71	217	5	1.10.418.10
Domain	Prefoldin	HIP1 FYCO1 KRT7 KRT14 KIF21A	1.50e-03	72	217	5	IPR009053
Domain	CH	ASPM LRCH2 SYNE1 MICALL2 LMO7	1.60e-03	73	217	5	PS50021
Domain	L_dom-like	LRRK2 LGR4 FBXO38 ZER1 NXF1 LRCH2 PRAMEF19 TLR10 LGI2 LRRC28 PHLPP2	1.64e-03	328	217	11	IPR032675
Domain	CH-domain	ASPM LRCH2 SYNE1 MICALL2 LMO7	1.80e-03	75	217	5	IPR001715
Domain	FAT	ATR PRKDC	1.95e-03	6	217	2	PS51189
Domain	FATC	ATR PRKDC	1.95e-03	6	217	2	PS51190
Domain	FAT	ATR PRKDC	1.95e-03	6	217	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR PRKDC	1.95e-03	6	217	2	IPR003151
Domain	FATC_dom	ATR PRKDC	1.95e-03	6	217	2	IPR003152
Domain	PIK_FAT	ATR PRKDC	1.95e-03	6	217	2	IPR014009
Domain	FATC	ATR PRKDC	1.95e-03	6	217	2	SM01343
Domain	Quino_amine_DH_bsu	LRRK2 TENM2 VPS8	2.02e-03	22	217	3	IPR011044
Domain	ABC_tran	ABCA13 ABCC8 ABCD2 ABCC9	2.31e-03	48	217	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCA13 ABCC8 ABCD2 ABCC9	2.31e-03	48	217	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCA13 ABCC8 ABCD2 ABCC9	2.49e-03	49	217	4	PS00211
Domain	ABC_transporter-like	ABCA13 ABCC8 ABCD2 ABCC9	2.69e-03	50	217	4	IPR003439
Domain	PI3K_Ras-bd_dom	PIK3C2A PIK3C2B	2.72e-03	7	217	2	IPR000341
Domain	LA	LARP6 LARP4	2.72e-03	7	217	2	SM00715
Domain	HTH_LA	LARP6 LARP4	2.72e-03	7	217	2	PS50961
Domain	PI3K_rbd	PIK3C2A PIK3C2B	2.72e-03	7	217	2	SM00144
Domain	La	LARP6 LARP4	2.72e-03	7	217	2	PF05383
Domain	PI3K_rbd	PIK3C2A PIK3C2B	2.72e-03	7	217	2	PF00794
Domain	PI3K_RBD	PIK3C2A PIK3C2B	2.72e-03	7	217	2	PS51546
Domain	Lupus_La_RNA-bd	LARP6 LARP4	2.72e-03	7	217	2	IPR006630
Domain	DHC_N1	DNAH9 DYNC2H1	3.59e-03	8	217	2	PF08385
Domain	LAMININ_IVA	LAMA1 LAMC2	3.59e-03	8	217	2	PS51115
Domain	Laminin_B	LAMA1 LAMC2	3.59e-03	8	217	2	PF00052
Domain	LamB	LAMA1 LAMC2	3.59e-03	8	217	2	SM00281
Domain	Dynein_heavy_dom-1	DNAH9 DYNC2H1	3.59e-03	8	217	2	IPR013594
Domain	Laminin_IV	LAMA1 LAMC2	3.59e-03	8	217	2	IPR000034
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	9.59e-15	35	182	12	MM17219
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	4.30e-14	39	182	12	MM17212
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	TRPC1 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	9.65e-14	53	182	13	MM15716
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	2.96e-13	45	182	12	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.92e-13	48	182	12	MM17214
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	3.19e-12	54	182	12	MM14655
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	5.07e-12	56	182	12	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	7.92e-12	58	182	12	MM14914
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.22e-11	60	182	12	MM14872
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.22e-11	60	182	12	MM14913
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 CYFIP2 ELMO2	2.20e-10	114	182	14	MM14814
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	7.50e-10	84	182	12	MM14653
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.27e-08	107	182	12	MM14915
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	TRPC1 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.39e-08	131	182	13	MM15717
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 TEK	1.31e-07	158	182	13	MM14812
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.70e-07	87	182	10	MM15351
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.73e-07	135	182	12	MM14781
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	HIP1 COPS2 IGHV3-64D CHMP7 AP2A2 PIK3C2A IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 BIN1 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 KIF21A VPS54 MADD TRAPPC12 GCC2 DNM3 DCTN4 ZW10	2.34e-07	645	182	26	MM15232
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	5.47e-07	150	182	12	MM14889
Pathway	REACTOME_AURKA_ACTIVATION_BY_TPX2	HMMR ALMS1 YWHAQ CEP290 YWHAG AKAP9 CDK5RAP2 CEP57	3.52e-06	71	182	8	MM15495
Pathway	REACTOME_AURKA_ACTIVATION_BY_TPX2	HMMR ALMS1 CEP290 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	3.91e-06	72	182	8	M27749
Pathway	WP_17P133_YWHAE_COPY_NUMBER_VARIATION	YWHAQ YWHAG YWHAH YWHAZ DCTN4	5.84e-06	21	182	5	M48088
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	6.56e-06	129	182	10	M27649
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	HIP1 COPS2 CHMP7 AP2A2 PIK3C2A YWHAQ IGHV3-53 IGHV3-48 BIN1 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 KIF21A VPS54 YWHAG YWHAH YWHAZ MADD TRAPPC12 GCC2 DNM3 DCTN4 ZW10	6.81e-06	725	182	25	M27507
Pathway	REACTOME_CELL_CYCLE	ATR NCAPH2 HMMR CHMP7 ALMS1 ANAPC1 ANAPC2 YWHAQ RB1 SYNE1 CEP290 NUMA1 RFC1 YWHAG YWHAH YWHAZ DMC1 AKAP9 NUP155 CENPH CDK5RAP2 ZW10 CEP57 PCNT	1.01e-05	694	182	24	M543
Pathway	REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA	YWHAQ YWHAG YWHAH YWHAZ	1.23e-05	12	182	4	MM14482
Pathway	REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS	YWHAQ YWHAG YWHAH YWHAZ	1.23e-05	12	182	4	M45022
Pathway	REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX	YWHAQ YWHAG YWHAH YWHAZ	1.23e-05	12	182	4	MM15443
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.29e-05	61	182	7	M27581
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	TRPC1 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.49e-05	86	182	8	M601
Pathway	KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY	YWHAQ YWHAG YWHAH YWHAZ	1.75e-05	13	182	4	M47589
Pathway	REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX	YWHAQ YWHAG YWHAH YWHAZ	1.75e-05	13	182	4	M27708
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	TRPC1 IGHV3-64D KLHL9 AP2A2 ANAPC1 ANAPC2 HACE1 IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 UBR4 YWHAZ LMO7 LTN1 DNM3 DCTN4	1.81e-05	719	182	24	MM14540
Pathway	REACTOME_PARASITE_INFECTION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 CYFIP2 ELMO2	1.90e-05	116	182	9	M29843
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	ALMS1 YWHAQ CEP290 NUMA1 YWHAG AKAP9 CDK5RAP2 CEP57	2.08e-05	90	182	8	MM14979
Pathway	WP_CELL_CYCLE	ATR ANAPC1 ANAPC2 YWHAQ RB1 YWHAG YWHAH YWHAZ PRKDC	2.50e-05	120	182	9	M39650
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMA1 YWHAQ LAMC2 YWHAG YWHAH YWHAZ	2.60e-05	46	182	6	M239
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	2.93e-05	69	182	7	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	2.93e-05	69	182	7	M27150
Pathway	REACTOME_KERATINIZATION	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	2.93e-05	153	182	10	MM15343
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	ALMS1 CEP290 NUMA1 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	3.09e-05	95	182	8	M6729
Pathway	REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA	YWHAQ YWHAG YWHAH YWHAZ	3.28e-05	15	182	4	M26902
Pathway	REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	ALMS1 YWHAQ CEP290 YWHAG C2CD3 AKAP9 CDK5RAP2 CEP57	3.33e-05	96	182	8	MM15207
Pathway	REACTOME_CELL_CYCLE	NCAPH2 HMMR CHMP7 ALMS1 ANAPC1 ANAPC2 YWHAQ RB1 CEP290 NUMA1 RFC1 YWHAG YWHAH YWHAZ DMC1 AKAP9 NUP155 CENPH CDK5RAP2 ZW10 CEP57	3.42e-05	603	182	21	MM14635
Pathway	KEGG_CELL_CYCLE	ATR ANAPC1 ANAPC2 YWHAQ RB1 YWHAG YWHAH YWHAZ PRKDC	3.46e-05	125	182	9	M7963
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	3.53e-05	71	182	7	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	3.53e-05	71	182	7	M27203
Pathway	REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	ALMS1 CEP290 YWHAG C2CD3 AKAP9 CDK5RAP2 CEP57 PCNT	3.59e-05	97	182	8	M27478
Pathway	REACTOME_SARS_COV_INFECTIONS	CHMP7 AP2A2 VPS33B PIK3C3 YWHAQ IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 RB1 PARP14 YWHAG YWHAH YWHAZ NUP155	3.90e-05	471	182	18	M39009
Pathway	REACTOME_M_PHASE	NCAPH2 CHMP7 ALMS1 ANAPC1 ANAPC2 YWHAQ RB1 CEP290 NUMA1 YWHAG AKAP9 NUP155 CENPH CDK5RAP2 ZW10 CEP57	4.22e-05	387	182	16	MM15364
Pathway	REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS	YWHAQ YWHAG YWHAH YWHAZ	4.33e-05	16	182	4	M46428
Pathway	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	YWHAQ YWHAG YWHAH YWHAZ	7.14e-05	18	182	4	MM14510
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	7.65e-05	80	182	7	M6121
Pathway	PID_PI3KCI_AKT_PATHWAY	YWHAQ YWHAG YWHAH YWHAZ PRKDC	8.05e-05	35	182	5	M249
Pathway	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	ALMS1 CEP290 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	8.28e-05	81	182	7	M748
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	8.96e-05	82	182	7	M27110
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 CYFIP2 ELMO2	9.88e-05	143	182	9	M27107
Pathway	REACTOME_M_PHASE	NCAPH2 CHMP7 ALMS1 ANAPC1 ANAPC2 RB1 CEP290 NUMA1 YWHAG AKAP9 NUP155 CENPH CDK5RAP2 ZW10 CEP57 PCNT	1.02e-04	417	182	16	M27662
Pathway	REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	ALMS1 YWHAQ CEP290 YWHAG AKAP9 CDK5RAP2 CEP57	1.13e-04	85	182	7	MM14906
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	ALMS1 YWHAQ DYNC2H1 CEP290 YWHAG C2CD3 AKAP9 TTC21B CDK5RAP2 CEP57 GABPB1	1.20e-04	217	182	11	MM14708
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.21e-04	86	182	7	M27206
Pathway	REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	ALMS1 CEP290 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	1.30e-04	87	182	7	M27194
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.30e-04	87	182	7	M27205
Pathway	PID_P38_MK2_PATHWAY	YWHAQ YWHAG YWHAH YWHAZ	1.35e-04	21	182	4	M199
Pathway	BIOCARTA_G2_PATHWAY	ATR YWHAQ YWHAH PRKDC	1.64e-04	22	182	4	MM1365
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_PKNS	YWHAQ YWHAG YWHAH YWHAZ	1.96e-04	23	182	4	MM15216
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	2.26e-04	95	182	7	M29842
Pathway	BIOCARTA_G2_PATHWAY	ATR YWHAQ YWHAH PRKDC	2.33e-04	24	182	4	M8560
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	2.74e-04	98	182	7	M27152
Pathway	REACTOME_CILIUM_ASSEMBLY	ALMS1 DYNC2H1 CEP290 YWHAG C2CD3 AKAP9 TTC21B CDK5RAP2 CEP57 PCNT	2.84e-04	201	182	10	M27472
Pathway	REACTOME_MITOTIC_PROMETAPHASE	ALMS1 YWHAQ CEP290 NUMA1 YWHAG AKAP9 CENPH CDK5RAP2 ZW10 CEP57	2.95e-04	202	182	10	MM15362
Pathway	REACTOME_MITOTIC_PROMETAPHASE	ALMS1 CEP290 NUMA1 YWHAG AKAP9 CENPH CDK5RAP2 ZW10 CEP57 PCNT	3.19e-04	204	182	10	M4217
Pathway	PID_INSULIN_GLUCOSE_PATHWAY	YWHAQ YWHAG YWHAH YWHAZ	3.22e-04	26	182	4	M247
Pathway	REACTOME_CELL_CYCLE_MITOTIC	NCAPH2 HMMR CHMP7 ALMS1 ANAPC1 ANAPC2 RB1 CEP290 NUMA1 RFC1 YWHAG AKAP9 NUP155 CENPH CDK5RAP2 ZW10 CEP57 PCNT	3.49e-04	561	182	18	M5336
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	YWHAQ YWHAG YWHAZ	4.27e-04	12	182	3	MM15657
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	YWHAQ YWHAG YWHAZ	4.27e-04	12	182	3	M27939
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	ALMS1 DYNC2H1 CEP290 MED1 YWHAG C2CD3 AKAP9 TTC21B CDK5RAP2 CEP57 GABPB1 PCNT	4.82e-04	297	182	12	M27050
Pathway	REACTOME_KERATINIZATION	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	5.20e-04	217	182	10	M27640
Pathway	REACTOME_SARS_COV_1_INFECTION	CHMP7 PIK3C3 YWHAQ RB1 PARP14 YWHAG YWHAH YWHAZ	5.35e-04	143	182	8	M39006
Pathway	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	YWHAQ YWHAG YWHAH YWHAZ	5.67e-04	30	182	4	M17814
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	7.23e-04	115	182	7	M19752
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	AP2A2 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	8.70e-04	154	182	8	M39007
Pathway	PID_PI3K_PLC_TRK_PATHWAY	YWHAQ YWHAG YWHAH YWHAZ	1.15e-03	36	182	4	M271
Pathway	REACTOME_HEMOSTASIS	IGHV3-64D IGHV3-74 PDE11A IGHV3-66 DOCK2 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 KIF21A TEK YWHAZ	1.17e-03	571	182	17	MM14472
Pathway	REACTOME_MEMBRANE_TRAFFICKING	HIP1 COPS2 CHMP7 AP2A2 PIK3C2A YWHAQ BIN1 KIF21A VPS54 YWHAG YWHAH YWHAZ MADD TRAPPC12 GCC2 DNM3 DCTN4 ZW10	1.34e-03	630	182	18	M11480
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	TRPC1 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.41e-03	166	182	8	M608
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	PIK3C2A PIK3C3 PI4KA	1.50e-03	18	182	3	M645
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	PIK3C2A PIK3C3 PI4KA	1.50e-03	18	182	3	MM14642
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	LAMA1 CLCA1 LAMC2 YWHAH YWHAZ	1.61e-03	66	182	5	MM15925
Pathway	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	YWHAQ YWHAG YWHAH YWHAZ	1.71e-03	40	182	4	MM14473
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.77e-03	134	182	7	M29840
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	RALGAPA1 FAM91A1 COPS2 PIK3C3 FGD5 YWHAQ RASAL2 DOCK2 ANKRD62 YWHAG YWHAH YWHAZ CYFIP2 ARHGAP5 ELMO2 CENPH DAAM1 ZW10	1.86e-03	649	182	18	MM15690
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.92e-03	136	182	7	M27207
Pathway	REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS	ANAPC1 ANAPC2 RB1	2.05e-03	20	182	3	M39015
Pathway	REACTOME_LEISHMANIA_INFECTION	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 CYFIP2 ELMO2	2.18e-03	219	182	9	M29836
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	PRSS3 ABCA13 IGHV3-64D AP2A2 PIK3C3 ATP6V1C2 IGHV3-74 IGHV3-66 DOCK2 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 UBR4 CEP290 LAMP1 CYFIP2 ELMO2 DNM3	2.22e-03	995	182	24	MM14661
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	TRPC1 KLHL9 AP2A2 ERAP2 PIK3C3 ANAPC1 ANAPC2 HACE1 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 UBR4 YWHAZ LMO7 LTN1 DNM3 DCTN4	2.34e-03	828	182	21	M1058
Pathway	KEGG_ABC_TRANSPORTERS	ABCA13 ABCC8 ABCD2 ABCC9	2.44e-03	44	182	4	M11911
Pathway	WP_CILIOPATHIES	TTLL5 DRC1 ALMS1 CNGA1 DYNC2H1 CEP290 C2CD3 TTC21B	2.69e-03	184	182	8	M39880
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	HMMR ALMS1 YWHAQ CEP290 YWHAG AKAP9 CDK5RAP2 CEP57	2.69e-03	184	182	8	MM15145
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	3.95e-24	15	240	12	12657787
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	5.38e-21	22	240	12	2499654
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	5.95e-18	77	240	15	15608191
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	8.49e-17	91	240	15	9841928
Pubmed	Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.	IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7	5.40e-12	39	240	9	8490662
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DAB2IP RALGAPA1 FAM91A1 FBXO38 WWC2 SMG7 VPS33B PI4KA YWHAQ KRT14 KRT18 CIP2A CEP290 ELP1 TFAP2A YWHAG YWHAH YWHAZ MADD CYFIP2 CNNM3 ARHGAP5 C2CD3 AKAP9 NUP155 LTN1 CSTF3 CDK5RAP2 CRYBG3 PHLPP2 PCNT	1.13e-11	1049	240	31	27880917
Pubmed	New consensus nomenclature for mammalian keratins.	KRT27 KRT25 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	1.88e-11	63	240	10	16831889
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP TRERF1 FYCO1 TENM2 CNTNAP5 AP2A2 ANAPC1 PI4KA YWHAQ RASAL2 BIN1 LRCH2 SYNE1 KIF21A UBR4 HECTD4 NUMA1 CNKSR2 YWHAG YWHAH YWHAZ CYFIP2 LRPPRC AGO1 AKAP9 DNM3 CDK5RAP2 RIMBP2 PCNT	3.55e-11	963	240	29	28671696
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RALGAPA1 RAPGEF6 ALMS1 AP2A2 VPS33B PIK3C2A ANAPC1 YWHAQ RASAL2 LRCH2 ELP1 FRYL YWHAG YWHAH YWHAZ CYFIP2 AKAP9 LMO7 PRKDC RASSF8	5.22e-11	446	240	20	24255178
Pubmed	Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.	LRRK2 YWHAQ YWHAG YWHAH YWHAZ	3.12e-10	7	240	5	21390248
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	USP9Y AP2A2 PIK3C2B YWHAQ KRT9 KRT12 KRT13 KRT14 KRT34 UBR4 ELP1 YWHAG AGO1 DNM3 PRKDC	6.45e-10	266	240	15	19380743
Pubmed	Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins.	YWHAQ KRT18 YWHAG YWHAH YWHAZ	8.26e-10	8	240	5	9524113
Pubmed	Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.	LRRK2 YWHAQ YWHAG YWHAH YWHAZ	8.26e-10	8	240	5	23075850
Pubmed	14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins.	YWHAQ YWHAG YWHAH YWHAZ ARHGAP5	8.26e-10	8	240	5	23622247
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	LARP6 MYO1A NEB RYR2 AP2A2 ASPM YWHAQ KRT7 KRT12 KRT13 KRT14 KRT18 KRT34 SYNE1 KIF21A UBR4 NUMA1 SRBD1 YWHAG YWHAH YWHAZ CYFIP2 KRT23 LRPPRC C2CD3 SLC25A12 LMO7 ANKRD30A PADI6 PRKDC NOSTRIN CEP57 PCNT	1.70e-09	1442	240	33	35575683
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 AARS1 RAPGEF6 WWC2 ALMS1 PIK3C2A PIK3C2B PIK3C3 PI4KA YWHAQ RASAL2 KRT18 FSD1 FRYL YWHAG YWHAH YWHAZ MADD LRPPRC C2CD3 AKAP9 LMO7 ELMO2 CRYBG3 RASSF8	1.83e-09	861	240	25	36931259
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ATR ANAPC1 PI4KA KRT7 KRT9 KRT14 NUMA1 FRYL MED1 PARP14 LTN1 ANKRD30A PRKDC	1.85e-09	202	240	13	33005030
Pubmed	IgD+IgM- B cells mount immune responses that exhibit altered antibody repertoire.	IGHV3-72 IGHV3-49 IGHV3-15 RFC1	1.10e-08	5	240	4	14991595
Pubmed	Molecular analysis of spontaneous somatic mutants.	IGHV3-48 IGHV3-21 IGHV3-11 IGHV3-7	1.10e-08	5	240	4	401950
Pubmed	Interaction with 14-3-3 adaptors regulates the sorting of hMex-3B RNA-binding protein to distinct classes of RNA granules.	YWHAQ YWHAG YWHAH YWHAZ AGO1	1.14e-08	12	240	5	18779327
Pubmed	14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.	LRRK2 YWHAQ YWHAG YWHAH YWHAZ	1.14e-08	12	240	5	20642453
Pubmed	Defining the membrane proteome of NK cells.	AARS1 FYCO1 NCAPH2 HMMR LARP4 PIK3C2A PIK3C3 PI4KA YWHAQ DOCK2 KRT9 UBR4 CEP290 B3GALT6 LAMP1 MED1 PARP14 YWHAG CYFIP2 CNNM3 LRPPRC PIGT NUP155 GCC2 PRKDC DAAM1 ZW10 PCNT	1.22e-08	1168	240	28	19946888
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	RAPGEF6 PIK3C3 YWHAQ RASAL2 KRT9 FRYL YWHAG YWHAH YWHAZ CYFIP2 LMO7 PRKDC RASSF8	3.02e-08	255	240	13	15324660
Pubmed	The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent.	YWHAQ YWHAG YWHAH YWHAZ	3.28e-08	6	240	4	19860830
Pubmed	The genomic organization of type I keratin genes in mice.	KRT27 KRT12 KRT13 KRT14 KRT34	4.26e-08	15	240	5	10087197
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	PIK3C2B YWHAQ YWHAG YWHAH YWHAZ CYFIP2 IGF2BP1 ELMO2 DNM3	4.36e-08	103	240	9	21706016
Pubmed	Differential Subcellular Distribution and Translocation of Seven 14-3-3 Isoforms in Response to EGF and During the Cell Cycle.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	31906564
Pubmed	14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	10620507
Pubmed	Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	36096339
Pubmed	Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	27030597
Pubmed	The expression of seven 14-3-3 isoforms in human meningioma.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	20388496
Pubmed	A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	12383250
Pubmed	Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members.	YWHAQ YWHAG YWHAH YWHAZ	7.62e-08	7	240	4	16868027
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PRSS3 AARS1 LARP6 TTLL5 NCAPH2 USP9Y NSUN2 NECAB1 SURF6 RASAL2 BIN1 SYNE1 KIF21A UBR4 CEP290 HECTD4 APBA1 VPS54 BLOC1S2 YWHAG YWHAH YWHAZ MADD ARHGAP5 LMO7 DNM3 PRKDC PCNT	8.99e-08	1285	240	28	35914814
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	PRSS3 FYCO1 PI4KA HOOK2 YWHAQ KRT7 KRT9 KRT13 KRT14 KRT18 PRAMEF19 CEP290 YWHAG YWHAZ SLC25A12 GUCY2C LTN1 PRKDC	9.41e-08	564	240	18	21565611
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	HMMR COPS2 HACE1 YWHAQ RB1 ELP1 YWHAG YWHAH RGS3 YWHAZ CNNM3 LTN1 DAAM1	1.02e-07	283	240	13	21903422
Pubmed	Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest.	YWHAQ YWHAG YWHAH YWHAZ	1.51e-07	8	240	4	15708996
Pubmed	BCR kinase phosphorylates 14-3-3 Tau on residue 233.	YWHAQ YWHAG YWHAH YWHAZ	1.51e-07	8	240	4	16045749
Pubmed	Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation.	YWHAQ YWHAG YWHAH YWHAZ	1.51e-07	8	240	4	18332103
Pubmed	Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.	ALMS1 CEP290 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	2.17e-07	61	240	7	7790358
Pubmed	Kank regulates RhoA-dependent formation of actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	18458160
Pubmed	Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	16581770
Pubmed	MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	16888623
Pubmed	14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	12438239
Pubmed	Identification and characterization of the interaction between tuberin and 14-3-3zeta.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	12176984
Pubmed	Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	16511560
Pubmed	14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	34294877
Pubmed	A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex.	YWHAQ YWHAG YWHAH YWHAZ	2.71e-07	9	240	4	12446771
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	NCAPH2 PIK3C3 ANAPC1 UBR4 ELP1 B3GALT6 LRPPRC SLC25A12 GCC2 LTN1 PCNT	2.98e-07	212	240	11	33853758
Pubmed	A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network.	DAB2IP TTLL5 ASPM LRPPRC IGF2BP1 AGO1	3.20e-07	40	240	6	20308539
Pubmed	Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex.	ALMS1 CEP290 YWHAG AKAP9 CDK5RAP2 CEP57 PCNT	3.76e-07	66	240	7	12221128
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	NEB ALMS1 PIK3C2A HOOK2 MYO18B BIN1 NRAP SYNE1 ELP1 BLOC1S2 YWHAZ LRPPRC AKAP9 CDK5RAP2 PAX7 NOSTRIN	4.42e-07	497	240	16	23414517
Pubmed	Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	14505491
Pubmed	Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	12433946
Pubmed	14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	25154416
Pubmed	SLy2 targets the nuclear SAP30/HDAC1 complex.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	20478393
Pubmed	Involvement of protein kinase PKN1 in G2/M delay caused by arsenite.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	15791647
Pubmed	Immunolocalization patterns of cytokeratins during salivary acinar cell development in mice.	KRT7 KRT13 KRT14 KRT18	4.50e-07	10	240	4	29181608
Pubmed	Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis.	YWHAQ YWHAG YWHAH YWHAZ	4.50e-07	10	240	4	11697890
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	AARS1 MYO1A KRT7 KRT18 CIP2A UBR4 LAMP1 YWHAG YWHAH YWHAZ KRT23 LRPPRC SLC25A12 LMO7 LTN1 PRKDC DAAM1 ZW10	6.96e-07	647	240	18	26618866
Pubmed	JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.	YWHAQ YWHAG YWHAH YWHAZ	7.03e-07	11	240	4	15696159
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	AARS1 RAPGEF6 ATR FAM91A1 HMMR NSUN2 ANAPC2 HOOK2 QSOX2 NXF1 RASAL2 ELP1 LAMC2 RGS3 MADD NUP155 ELMO2 CRYBG3	7.43e-07	650	240	18	38777146
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SMG7 ALMS1 PIK3C2B ANAPC1 PI4KA ASPM NXF1 KRT9 KRT14 RB1 DYNC2H1 CIP2A ELP1 LMO7 CENPH CRYBG3 PCNT	8.48e-07	588	240	17	38580884
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AARS1 LARP4 NSUN2 AP2A2 VPS33B PIK3C2A PI4KA ASPM YWHAQ NXF1 RASAL2 KRT18 RB1 KIF21A UBR4 NUMA1 ELP1 RFC1 SRBD1 YWHAG YWHAZ LRPPRC SLC25A12 NUP155 LTN1 PRKDC DCTN4	8.58e-07	1353	240	27	29467282
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	TTLL5 ALMS1 CEP290 C2CD3 AKAP9 CDK5RAP2 DCTN4 CEP57 PCNT	8.69e-07	146	240	9	21399614
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	WWC2 PIK3C2B YWHAQ HECTD4 NUMA1 RFC1 YWHAZ LRPPRC LMO7 PRKDC	9.11e-07	190	240	10	15161933
Pubmed	The subcortical maternal complex modulates the cell cycle during early mammalian embryogenesis via 14-3-3.	YWHAQ YWHAG YWHAH YWHAZ	1.05e-06	12	240	4	39406751
Pubmed	Divergent regulation of functionally distinct γ-tubulin complexes during differentiation.	YWHAQ KRT14 CDK5RAP2 PCNT	1.05e-06	12	240	4	27298324
Pubmed	Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.	PIK3C2A PIK3C2B PIK3C3 CCR5	1.05e-06	12	240	4	12551992
Pubmed	Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.	YWHAQ YWHAG YWHAH YWHAZ	1.05e-06	12	240	4	19172738
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP FAM91A1 TENM2 LRCH2 SYNE1 VPS8 CNKSR2 MADD AKAP9 LGI2 GCC2 DNM3 RIMBP2 PCNT	1.09e-06	407	240	14	12693553
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	AARS1 PI4KA YWHAQ NXF1 YWHAG YWHAH YWHAZ LRPPRC SLC25A12 PRKDC	1.27e-06	197	240	10	31620119
Pubmed	A biological consequence of variation in the site of D-JH gene rearrangement.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	6434992
Pubmed	An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	6769593
Pubmed	Structural interface between LRRK2 and 14-3-3 protein.	LRRK2 YWHAG YWHAZ	1.29e-06	4	240	3	28202711
Pubmed	Crossreactive B cells are present during a primary but not secondary response in BALB/c mice expressing a bcl-2 transgene.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	10449099
Pubmed	Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	3135325
Pubmed	Structure of the T15 VH gene subfamily: identification of immunoglobulin gene promotor homologies.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	3108392
Pubmed	The D segment defines the T15 idiotype: the immunoresponse of A/J mice to Pneumococcus pneumoniae.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	6499907
Pubmed	Antibody diversity: somatic hypermutation of rearranged VH genes.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	6101208
Pubmed	Developmentally controlled expression of immunoglobulin VH genes.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	3975629
Pubmed	Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	106394
Pubmed	Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	25127856
Pubmed	Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	8046334
Pubmed	Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	12734355
Pubmed	Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	21068211
Pubmed	Identification of a novel ATPase activity in 14-3-3 proteins--evidence from enzyme kinetics, structure guided modeling and mutagenesis studies.	YWHAQ YWHAG YWHAZ	1.29e-06	4	240	3	24269678
Pubmed	Mouse monoclonal antibodies to pneumococcal C-polysaccharide backbone show restricted usage of VH-DH-JH gene segments and share the same kappa chain.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	19428559
Pubmed	Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis.	PIK3C2A PIK3C2B PIK3C3	1.29e-06	4	240	3	24098492
Pubmed	Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	25157256
Pubmed	Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	2748602
Pubmed	ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.	ZER1 RB1 UBR4	1.29e-06	4	240	3	36346242
Pubmed	An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	6296789
Pubmed	Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	3106498
Pubmed	Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	8750831
Pubmed	Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	819932
Pubmed	Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	3104790
Pubmed	CPAP interacts with 14-3-3 in a cell cycle-dependent manner.	YWHAQ YWHAG YWHAZ	1.29e-06	4	240	3	16516142
Pubmed	A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	2005389
Pubmed	Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.	IGHV3-72 IGHV3-49 IGHV3-15	1.29e-06	4	240	3	2512348
Interaction	KRT8 interactions	RAPGEF6 KRT27 TTLL5 SMG7 ALMS1 ZER1 FGD5 TADA2A YWHAQ KRT25 KRT7 KRT12 KRT13 KRT14 KRT18 KRT34 UBR4 ELP1 YWHAG YWHAH YWHAZ KRT23 AKAP9 LTN1 CDK5RAP2 CRYBG3 CEP57 PDZRN3 PCNT	1.80e-14	441	226	29	int:KRT8
Interaction	NDC80 interactions	KRT27 TTLL5 HMMR SFR1 NSUN2 ALMS1 ANAPC2 ASPM NXF1 RB1 CIP2A CEP290 C2CD3 AKAP9 GCC2 CENPH CDK5RAP2 ZW10 PCNT	2.63e-09	312	226	19	int:NDC80
Interaction	CCDC18 interactions	VPS33B ANAPC2 YWHAQ KRT18 CEP290 YWHAG YWHAH YWHAZ CDK5RAP2 PCNT	4.25e-09	68	226	10	int:CCDC18
Interaction	C3orf18 interactions	ATR FAM91A1 NCAPH2 PI4KA PRMT9 DYNC2H1 CIP2A VPS8 ELMO2 LTN1 PRKDC ZW10	6.59e-09	115	226	12	int:C3orf18
Interaction	KRT72 interactions	KRT27 FYCO1 KRT25 KRT7 KRT13 KRT14 KRT18 KRT34 NUMA1	1.85e-08	59	226	9	int:KRT72
Interaction	DUSP16 interactions	RAPGEF6 SMG7 ALMS1 PIK3C2A ANAPC1 YWHAQ DYNC2H1 ATG2B YWHAG YWHAH YWHAZ MEIOC CDK5RAP2 PDZRN3 PCNT	7.92e-08	237	226	15	int:DUSP16
Interaction	MPHOSPH9 interactions	VPS33B ANAPC2 YWHAQ KRT18 CEP290 YWHAG YWHAH YWHAZ NUP155 PCNT	1.13e-07	95	226	10	int:MPHOSPH9
Interaction	CSPP1 interactions	VPS33B ANAPC2 ASPM KRT18 CIP2A CEP290 YWHAG YWHAH DCTN4 PCNT	1.25e-07	96	226	10	int:CSPP1
Interaction	KRT77 interactions	KRT27 LGR4 KRT25 KRT7 KRT14 KRT18 KRT34 YWHAG YWHAH YWHAZ	1.25e-07	96	226	10	int:KRT77
Interaction	KRT4 interactions	KRT27 KRT25 KRT13 KRT14 KRT18 KRT34 NUMA1 CEP57	4.44e-07	62	226	8	int:KRT4
Interaction	LRRC31 interactions	ATR ANAPC1 PI4KA KRT7 KRT9 KRT14 NUMA1 FRYL MED1 PARP14 LTN1 ANKRD30A PRKDC	5.80e-07	205	226	13	int:LRRC31
Interaction	PCNT interactions	ALMS1 NECAB1 ANAPC2 KRT18 SYNE1 CEP290 YWHAH YWHAZ MADD AKAP9 DNM3 CDK5RAP2 CEP57 PCNT	6.14e-07	241	226	14	int:PCNT
Interaction	KRT19 interactions	TTLL5 SMG7 ALMS1 YWHAQ KRT7 KRT12 KRT14 KRT18 CEP290 YWHAG YWHAH AKAP9 GCC2 CDK5RAP2 PCNT	7.41e-07	282	226	15	int:KRT19
Interaction	KCNK15 interactions	YWHAQ YWHAG YWHAH YWHAZ	1.04e-06	8	226	4	int:KCNK15
Interaction	CCDC138 interactions	KRT27 TCEANC SMG7 VPS33B ANAPC2 KRT18 CEP290 YWHAH CEP57 PCNT	1.28e-06	123	226	10	int:CCDC138
Interaction	CEP95 interactions	KRT27 HOOK2 YWHAQ NXF1 YWHAG YWHAH YWHAZ	1.35e-06	50	226	7	int:CEP95
Interaction	KLC4 interactions	ANAPC2 TADA2A YWHAQ KRT13 KRT34 YWHAG YWHAH YWHAZ AKAP9 CEP57	1.48e-06	125	226	10	int:KLC4
Interaction	CEP85L interactions	YWHAQ YWHAG YWHAH YWHAZ PIGT PCNT	1.60e-06	33	226	6	int:CEP85L
Interaction	CEP192 interactions	ALMS1 ANAPC2 YWHAQ NXF1 KRT18 CIP2A YWHAG YWHAH YWHAZ NUP155 CDK5RAP2 PCNT	1.85e-06	192	226	12	int:CEP192
Interaction	KCNK9 interactions	YWHAQ YWHAG YWHAH YWHAZ	1.86e-06	9	226	4	int:KCNK9
Interaction	PCM1 interactions	TTLL5 HMMR LARP4 SMG7 VPS33B YWHAQ KRT14 CEP290 YWHAG YWHAH YWHAZ C2CD3 AKAP9 GCC2 CDK5RAP2 RASSF8 PDZRN3 PCNT	2.13e-06	434	226	18	int:PCM1
Interaction	YWHAH interactions	DAB2IP RALGAPA1 RAPGEF6 LRRK2 WWC2 ALMS1 PIK3C2A PIK3C2B PIK3C3 PI4KA YWHAQ RASAL2 LRCH2 KRT18 CEP290 HECTD4 LAMP1 FSD1 FRYL MED1 YWHAG YWHAH YWHAZ MADD CYFIP2 C2CD3 AKAP9 LMO7 CRYBG3 RASSF8 PCNT	2.23e-06	1102	226	31	int:YWHAH
Interaction	DTNBP1 interactions	KRT27 SFR1 ALMS1 ASPM SYNE1 CEP290 LAMC2 BLOC1S2 CYFIP2 CDK5RAP2 PCNT	2.24e-06	162	226	11	int:DTNBP1
Interaction	SMTNL2 interactions	LRRK2 YWHAQ KRT7 YWHAG YWHAH YWHAZ	2.30e-06	35	226	6	int:SMTNL2
Interaction	TRIM52 interactions	TTLL5 FAM91A1 NCAPH2 ALMS1 ASPM CEP290 MEIOC CDK5RAP2 PDZRN3 PCNT	2.61e-06	133	226	10	int:TRIM52
Interaction	EXPH5 interactions	FYCO1 NCAPH2 YWHAQ YWHAG YWHAH YWHAZ KRT23	2.96e-06	56	226	7	int:EXPH5
Interaction	C1orf87 interactions	LRRK2 UBR4 AKAP9 CDK5RAP2 PCNT	2.98e-06	21	226	5	int:C1orf87
Interaction	SPATA13 interactions	GLDC YWHAQ YWHAG YWHAH YWHAZ	2.98e-06	21	226	5	int:SPATA13
Interaction	OTOG interactions	YWHAQ YWHAG YWHAH YWHAZ	3.07e-06	10	226	4	int:OTOG
Interaction	KRT1 interactions	KRT27 LGR4 FGD5 HOOK2 YWHAQ KRT25 KRT7 KRT9 KRT13 KRT14 CALB2 KRT18 KRT34	3.08e-06	238	226	13	int:KRT1
Interaction	PFKFB4 interactions	YWHAQ NXF1 YWHAG YWHAH YWHAZ PRKDC	3.81e-06	38	226	6	int:PFKFB4
Interaction	PPP1R3D interactions	YWHAQ YWHAG YWHAH YWHAZ LRPPRC	3.82e-06	22	226	5	int:PPP1R3D
Interaction	KRT79 interactions	KRT27 LGR4 KRT25 KRT13 KRT14 KRT18 KRT34	4.22e-06	59	226	7	int:KRT79
Interaction	INA interactions	KRT27 YWHAQ KRT7 KRT14 KRT18 CNKSR2 YWHAG YWHAH YWHAZ CYFIP2 KRT23	4.24e-06	173	226	11	int:INA
Interaction	NINL interactions	TTLL5 TCEANC SMG7 ALMS1 VPS33B PIK3C2A ANAPC2 DYNC2H1 CEP290 YWHAG YWHAH LRPPRC MEIOC LMO7 PRKDC RASSF8 DCTN4 PCNT	4.51e-06	458	226	18	int:NINL
Interaction	ABI2 interactions	KRT27 NXF1 TRIM72 CCDC74B KRT13 KRT14 KRT34 LAMP1 YWHAH YWHAZ CYFIP2 AKAP9 CENPH CEP57	4.60e-06	286	226	14	int:ABI2
Interaction	CDCA7 interactions	YWHAQ YWHAG YWHAH YWHAZ	4.78e-06	11	226	4	int:CDCA7
Interaction	CCDC8 interactions	NSUN2 PI4KA YWHAQ KRT14 KRT18 MROH2A CEP290 NUMA1 ELP1 LAMP1 YWHAG YWHAH YWHAZ CNNM3 LRPPRC IGF2BP1 AGO1 NUP155 LMO7 PRKDC CEP57 PCNT	5.06e-06	656	226	22	int:CCDC8
Interaction	KANK1 interactions	YWHAQ NXF1 KIF21A YWHAG YWHAH YWHAZ	5.19e-06	40	226	6	int:KANK1
Interaction	C19orf38 interactions	NCAPH2 PRMT9 DYNC2H1 CIP2A VPS8 CYFIP2 LTN1 PRKDC	5.53e-06	86	226	8	int:C19orf38
Interaction	CEP152 interactions	SMG7 ALMS1 VPS33B ANAPC2 KRT18 CIP2A YWHAH CDK5RAP2 RASSF8 CEP57 PCNT	5.88e-06	179	226	11	int:CEP152
Interaction	PXN interactions	TCEANC SMG7 ALMS1 AP2A2 PIK3C2A PI4KA NXF1 ARHGAP5 AKAP9 GCC2 CDK5RAP2 CRYBG3 RASSF8 ZW10 PCNT	5.97e-06	334	226	15	int:PXN
Interaction	KRT78 interactions	KRT27 KRT25 KRT13 KRT14 KRT34 NUMA1 YWHAH YWHAZ	6.03e-06	87	226	8	int:KRT78
Interaction	PACS2 interactions	ASPM YWHAQ YWHAG YWHAH YWHAZ	6.06e-06	24	226	5	int:PACS2
Interaction	KRT75 interactions	KRT27 LGR4 KRT25 KRT7 KRT12 KRT13 KRT14 KRT18 KRT34 NUMA1 CEP57	6.54e-06	181	226	11	int:KRT75
Interaction	PPP1R3E interactions	YWHAQ YWHAG YWHAH YWHAZ	7.10e-06	12	226	4	int:PPP1R3E
Interaction	CEP350 interactions	VPS33B ANAPC2 YWHAQ NXF1 KRT18 CEP290 YWHAG YWHAH CDK5RAP2 PCNT	7.23e-06	149	226	10	int:CEP350
Interaction	GOLGA1 interactions	RAPGEF6 KRT27 FAM91A1 SMG7 ALMS1 UBR4 ATG2B VPS54 GCC2 CRYBG3 PCNT	7.27e-06	183	226	11	int:GOLGA1
Interaction	APC interactions	NEB COPS2 ANAPC2 YWHAQ KRT13 KRT14 KRT18 SYNE1 TFAP2A YWHAG YWHAH YWHAZ KRT23 GUCY2C NOSTRIN ZW10	8.83e-06	389	226	16	int:APC
Interaction	EML3 interactions	ALMS1 ANAPC1 YWHAQ NUMA1 YWHAG YWHAH YWHAZ	9.02e-06	66	226	7	int:EML3
Interaction	FAM83G interactions	YWHAQ NXF1 YWHAG YWHAH YWHAZ	9.21e-06	26	226	5	int:FAM83G
Interaction	SAMD4B interactions	SMG7 ALMS1 PIK3C2A YWHAQ YWHAG YWHAH YWHAZ IGF2BP1 AGO1	9.74e-06	122	226	9	int:SAMD4B
Interaction	KCNK3 interactions	YWHAQ YWHAG YWHAH YWHAZ	1.02e-05	13	226	4	int:KCNK3
Interaction	LATS1 interactions	LRRK2 NEB WWC2 SMG7 ALMS1 ANAPC1 PTPRQ YWHAQ CEP290 YWHAG YWHAH YWHAZ IGF2BP1 AKAP9 CDK5RAP2 RASSF8 PCNT	1.04e-05	440	226	17	int:LATS1
Interaction	RGS12 interactions	YWHAQ CACNA1B YWHAG YWHAH YWHAZ LTN1	1.05e-05	45	226	6	int:RGS12
Interaction	KRT5 interactions	KRT27 LGR4 FGD5 KRT25 KRT7 KRT12 KRT13 KRT14 KRT18 KRT34 CEP290	1.20e-05	193	226	11	int:KRT5
Interaction	MTMR4 interactions	ATR NCAPH2 SMG7 AP2A2 YWHAQ YWHAG YWHAH YWHAZ MADD ZNF669	1.21e-05	158	226	10	int:MTMR4
Interaction	CEP135 interactions	TTLL5 SMG7 ALMS1 PIK3C2B CEP290 YWHAH C2CD3 AKAP9 NUP155 LMO7 ELMO2 CDK5RAP2 PCNT	1.31e-05	272	226	13	int:CEP135
Interaction	SPAG5 interactions	IGFN1 KRT27 ANAPC2 KRT18 MED1 YWHAZ KRT23 TRAPPC12 CENPH ANKRD30A ZW10	1.32e-05	195	226	11	int:SPAG5
Interaction	CARMIL2 interactions	YWHAQ YWHAG YWHAH YWHAZ CYFIP2	1.35e-05	28	226	5	int:CARMIL2
Interaction	KIAA0930 interactions	YWHAQ FRYL YWHAG YWHAH YWHAZ	1.35e-05	28	226	5	int:KIAA0930
Interaction	WWC2 interactions	WWC2 YWHAQ YWHAG YWHAH YWHAZ	1.35e-05	28	226	5	int:WWC2
Interaction	DENND2B interactions	YWHAQ YWHAG YWHAH YWHAZ MADD	1.35e-05	28	226	5	int:DENND2B
Interaction	KRT6A interactions	KRT27 LGR4 FGD5 KRT25 KRT7 KRT12 KRT13 KRT14 KRT18 KRT34	1.35e-05	160	226	10	int:KRT6A
Interaction	NIN interactions	TTLL5 HMMR SMG7 ALMS1 VPS33B KRT18 CEP290 YWHAH YWHAZ C2CD3 MEIOC RASSF8 DCTN4 PDZRN3 PCNT	1.41e-05	359	226	15	int:NIN
Interaction	VASH2 interactions	LRRK2 YWHAQ YWHAG YWHAH	1.41e-05	14	226	4	int:VASH2
Interaction	NEFL interactions	KRT27 KRT7 KRT13 KRT14 KRT18 CNKSR2 YWHAG YWHAZ KRT23 CDK5RAP2	1.43e-05	161	226	10	int:NEFL
Interaction	TCP10L interactions	LRRK2 FYCO1 TCEANC NXF1 NUMA1 GCC2 PCNT	1.47e-05	71	226	7	int:TCP10L
Interaction	SHC1 interactions	PRSS3 USP9Y AP2A2 PIK3C2B NXF1 RASAL2 KRT9 KRT13 KRT14 KRT18 RB1 ELP1 TEK YWHAG PRKDC	1.55e-05	362	226	15	int:SHC1
Interaction	SPEG interactions	ASPM YWHAQ YWHAG YWHAH YWHAZ	1.62e-05	29	226	5	int:SPEG
Interaction	PIBF1 interactions	IGFN1 VPS33B ANAPC2 PTPRQ NXF1 KRT18 CEP290 YWHAG YWHAH CDK5RAP2 PCNT	1.68e-05	200	226	11	int:PIBF1
Interaction	ALMS1 interactions	NCAPH2 ALMS1 ANAPC2 KRT18 YWHAG YWHAH NUP155 DNM3 CDK5RAP2 PCNT	1.68e-05	164	226	10	int:ALMS1
Interaction	KRT6B interactions	KRT27 FGD5 KRT25 KRT7 KRT12 KRT13 KRT14 KRT18 YWHAZ	1.84e-05	132	226	9	int:KRT6B
Interaction	TICRR interactions	FBXO38 YWHAQ YWHAG YWHAH YWHAZ	1.92e-05	30	226	5	int:TICRR
Interaction	MARK1 interactions	LRRK2 YWHAQ APBA1 YWHAG YWHAH YWHAZ AGO1	1.93e-05	74	226	7	int:MARK1
Interaction	GSK3A interactions	RAPGEF6 DRC1 SMG7 ALMS1 YWHAQ RASAL2 LRCH2 CIP2A KIF21A ATG2B SRBD1 YWHAG YWHAH AKAP9 PRKDC CRYBG3 RASSF8	2.07e-05	464	226	17	int:GSK3A
Interaction	DFFA interactions	LRRK2 NSUN2 PIK3C3 NXF1 YWHAG YWHAZ PRKDC	2.11e-05	75	226	7	int:DFFA
Interaction	TP73 interactions	DAB2IP TTLL5 NCAPH2 ASPM BIN1 RB1 LRPPRC IGF2BP1 AGO1 DNM3	2.18e-05	169	226	10	int:TP73
Interaction	MAP3K9 interactions	AP2A2 YWHAQ YWHAG YWHAH YWHAZ	2.27e-05	31	226	5	int:MAP3K9
Interaction	KRT6C interactions	KRT27 KRT25 KRT7 KRT13 KRT14 KRT18 KRT34	2.30e-05	76	226	7	int:KRT6C
Interaction	USP43 interactions	YWHAQ YWHAG YWHAH YWHAZ CDK5RAP2 CEP57	2.46e-05	52	226	6	int:USP43
Interaction	SAMSN1 interactions	YWHAQ YWHAG YWHAH YWHAZ	2.52e-05	16	226	4	int:SAMSN1
Interaction	CLASP1 interactions	YWHAQ LAMP1 YWHAG YWHAH YWHAZ GCC2 CENPH DCTN4 ZW10	2.62e-05	138	226	9	int:CLASP1
Interaction	CEP112 interactions	YWHAQ YWHAG YWHAH YWHAZ CDK5RAP2	2.67e-05	32	226	5	int:CEP112
Interaction	KRT81 interactions	KRT27 KRT25 KRT13 KRT14 KRT18 KRT34	2.75e-05	53	226	6	int:KRT81
Interaction	DISC1 interactions	TCEANC SEMA3A ALMS1 NECAB1 YWHAQ NXF1 SYNE1 CEP290 LAMP1 FSD1 FRYL YWHAG YWHAZ AKAP9 CEP57 PCNT	2.93e-05	429	226	16	int:DISC1
Interaction	YWHAZ interactions	DAB2IP RALGAPA1 RAPGEF6 LRRK2 LGR4 NEB WWC2 MYO3A PIK3C2A PIK3C2B PIK3C3 YWHAQ NXF1 RASAL2 BIN1 KRT18 HECTD4 CNKSR2 FRYL YWHAG YWHAH RGS3 YWHAZ MADD CYFIP2 LRPPRC AKAP9 LMO7 GCC2 CDK5RAP2 RASSF8 PCNT	3.08e-05	1319	226	32	int:YWHAZ
Interaction	SH3BP5L interactions	YWHAQ YWHAG YWHAH YWHAZ CEP57	3.12e-05	33	226	5	int:SH3BP5L
Interaction	KRT7 interactions	KRT27 FGD5 KRT7 KRT12 KRT13 KRT14 KRT18	3.22e-05	80	226	7	int:KRT7
Interaction	ZNF395 interactions	YWHAQ YWHAG YWHAH YWHAZ	3.27e-05	17	226	4	int:ZNF395
Interaction	CEP128 interactions	TTLL5 SMG7 ALMS1 VPS33B NXF1 RASAL2 KRT18 CIP2A CEP290 YWHAH C2CD3 SLC25A12 LMO7	3.29e-05	297	226	13	int:CEP128
Interaction	CALM3 interactions	HIP1 LRRK2 ASPM NXF1 IQCG LRCH2 UBR4 CEP290 TEK YWHAZ LRPPRC AKAP9 LMO7 PCNT	3.53e-05	343	226	14	int:CALM3
Interaction	CDC14A interactions	YWHAQ KRT18 CEP290 YWHAG YWHAH YWHAZ LRPPRC C2CD3	3.62e-05	111	226	8	int:CDC14A
Interaction	SFN interactions	RALGAPA1 AARS1 RAPGEF6 LRRK2 NEB WWC2 ALMS1 PIK3C2A PIK3C2B YWHAQ RASAL2 KRT18 FRYL YWHAG YWHAH YWHAZ CYFIP2 PIGT AKAP9 LMO7 CRYBG3	3.69e-05	692	226	21	int:SFN
Interaction	CRYL1 interactions	SMG7 ALMS1 PIK3C2A ANAPC1 DYNC2H1 UBR4	3.78e-05	56	226	6	int:CRYL1
Interaction	GRK5 interactions	COPS2 AP2A2 YWHAQ NXF1 FRYL YWHAG YWHAZ MADD LRPPRC PRKDC	4.11e-05	182	226	10	int:GRK5
Interaction	CPAP interactions	SMG7 ALMS1 ANAPC2 NXF1 YWHAG YWHAH YWHAZ C2CD3 CENPH PCNT	4.11e-05	182	226	10	int:CPAP
Interaction	FAM53B interactions	YWHAQ YWHAG YWHAH YWHAZ	4.17e-05	18	226	4	int:FAM53B
Interaction	DOCK11 interactions	YWHAQ UBR4 YWHAG YWHAH YWHAZ ARHGAP5	4.19e-05	57	226	6	int:DOCK11
Interaction	NUP107 interactions	ANAPC2 YWHAQ NXF1 SYNE1 NUMA1 YWHAZ NUP155 TRAPPC12 CENPH PRKDC ZW10	4.21e-05	221	226	11	int:NUP107
Cytoband	14q32.33	IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-30-3	3.41e-16	228	239	18	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 ATG2B	9.48e-09	566	239	17	chr14q32
Cytoband	Ensembl 112 genes in cytogenetic band chr17q21	KRT27 KRT25 KRT9 KRT12 KRT13 KRT14 KRT34 KRT23 IGF2BP1 MEIOC	2.09e-04	473	239	10	chr17q21
Cytoband	17q21.2	KRT27 KRT25 KRT34 KRT23	5.02e-04	70	239	4	17q21.2
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-30-5 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-3	2.83e-14	187	177	19	349
GeneFamily	Keratins, type I	KRT27 KRT25 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	3.96e-12	28	177	9	608
GeneFamily	14-3-3 phospho-serine/phospho-threonine binding proteins	YWHAQ YWHAG YWHAH YWHAZ	3.04e-07	7	177	4	1053
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2A PIK3C2B PIK3C3	4.98e-05	8	177	3	831
Coexpression	XU_CREBBP_TARGETS_DN	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.88e-14	56	232	12	MM642
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 KRT18 IGHV3-7	6.82e-12	102	232	13	MM872
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	2.38e-09	132	232	12	MM996
Coexpression	HALLMARK_MITOTIC_SPINDLE	RAPGEF6 ALMS1 RASAL2 DOCK2 BIN1 NUMA1 RFC1 ARHGAP5 LRPPRC CDK5RAP2 CEP57 PCNT	2.33e-07	199	232	12	M5893
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	IGFN1 RAPGEF6 LRRK2 PGM2L1 NEB TENM2 RYR2 SEMA3A SERPINI1 ERAP2 RASAL2 PDE11A KRT14 CALB2 KIF21A APBA1 LAMC2 YWHAG CYFIP2 SLC25A12 AKAP9 LGI2 DNM3 RIMBP2 DAAM1	1.80e-05	1106	232	25	M39071
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	MYO1A LAMA1 CLCA1 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7	8.48e-09	183	222	14	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	MYO1A CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	1.78e-08	163	222	13	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	MYO1A CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	4.15e-08	175	222	13	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	MYO1A CLCA1 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7	7.04e-08	183	222	13	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	MYO1A LAMA1 CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	3.10e-07	244	222	14	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	MYO1A CLCA1 IGHV3-72 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7	8.53e-07	126	222	10	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	MYO1A CLCA1 IGHV3-72 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7	2.10e-06	139	222	10	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	MYO1A CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	4.88e-06	266	222	13	Arv_SC-hpx_blastocyst_1000_K2
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ATR TRPC1 ALMS1 RB1 CNKSR2 DMC1 MEIOC PRKDC	2.85e-05	115	222	8	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	ATR TRPC1 TTLL5 PGM2L1 LARP4 ALMS1 VPS33B GLDC HACE1 PRMT9 RASAL2 RB1 CIP2A CNKSR2 SRBD1 TDRD1 MADD DMC1 LRPPRC MEIOC CENPH PRKDC	5.29e-05	820	222	22	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	GLDC ASPM RB1 DYNC2H1 KIF21A CYFIP2 AKAP9 GCC2	1.10e-04	139	222	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ATR PGM2L1 ALMS1 RASAL2 RB1 DMC1 PRKDC	1.59e-04	110	222	7	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2	LGR4 PTPRQ FGD5 RASAL2 CACNA1B KRT7 KRT9 KRT14 KRT18 KIF21A LAMC2 DAAM1 NOSTRIN	2.15e-04	384	222	13	GSM777041_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	RALGAPA1 LARP6 PGM2L1 GPR63 RYR2 PIK3C2A ANAPC1 MED1 YWHAG IGF2BP1 C2CD3 AKAP9 DCTN4	2.21e-04	385	222	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	MYO1A CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 HES3 UNC45B	2.23e-04	492	222	15	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	MYO1A CLCA1 IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 HES3 UNC45B	2.23e-04	492	222	15	Arv_SC-hpx_blastocyst_500
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	AARS1 GLDC IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7	5.76e-16	196	237	17	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.24e-13	190	237	15	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.24e-13	190	237	15	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.57e-13	193	237	15	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.69e-13	194	237	15	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	ASPM IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.96e-13	196	237	15	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 TLR10	2.12e-13	197	237	15	2662138671262b30508c5759038bcdcfe6551696
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	AARS1 GLDC ASPM IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	2.12e-13	197	237	15	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	2.63e-12	193	237	14	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	6.60e-12	167	237	13	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	6.60e-12	167	237	13	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GLDC ASPM IGHV3-74 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.38e-11	177	237	13	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GLDC ASPM IGHV3-74 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.38e-11	177	237	13	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GLDC ASPM IGHV3-74 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.38e-11	177	237	13	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLDC IGHV3-74 IGHV3-72 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.59e-11	179	237	13	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLDC IGHV3-74 IGHV3-72 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.59e-11	179	237	13	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	2.41e-11	185	237	13	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	2.41e-11	185	237	13	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	AARS1 GLDC IGHV3-74 IGHV3-72 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7	4.10e-11	193	237	13	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	4.66e-11	195	237	13	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 USP9Y NEB CNTNAP5 MYLK4 PTPRQ DNAH9 CNGA1 PDE11A CACNA1B A1CF CIP2A	7.73e-11	162	237	12	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-64D CNGA1 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 TLR10 GUCY2C	1.27e-10	169	237	12	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	GLDC IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 IGF2BP1	2.17e-10	177	237	12	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 TLR10	2.31e-10	178	237	12	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLDC IGHV3-72 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	2.47e-10	179	237	12	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-64D IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7	2.80e-10	181	237	12	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLDC IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7	3.18e-10	183	237	12	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-64D IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	3.61e-10	185	237	12	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 ZNF148 ATR PIK3C2A KIF21A FRYL MED1 LRPPRC AKAP9 GCC2 PRKDC CRYBG3	5.87e-10	193	237	12	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	GLDC IGHV3-74 IGHV3-72 IGHV3-53 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 ANKRD62	6.19e-10	152	237	11	a2ba2d95ac9010e1a62db34dcad10d004f8a90cc
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	6.60e-10	195	237	12	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 TLR10	7.42e-10	197	237	12	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	AARS1 GLDC ASPM IGHV3-74 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	8.33e-10	199	237	12	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HMMR GLDC ASPM IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-23 IGHV3-11	1.58e-09	166	237	11	2b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-64D CNGA1 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	2.03e-09	170	237	11	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-64D CNGA1 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	2.03e-09	170	237	11	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-64D CNGA1 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	2.03e-09	170	237	11	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	GLDC IGHV3-74 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-9 IGHV3-7	2.93e-09	176	237	11	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	GLDC IGHV3-74 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-9 IGHV3-7	2.93e-09	176	237	11	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 TLR10	4.41e-09	183	237	11	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	4.67e-09	184	237	11	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	4.67e-09	184	237	11	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	4.67e-09	184	237	11	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10 GUCY2C	4.67e-09	184	237	11	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-64D IGHV3-74 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	4.94e-09	185	237	11	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-64D IGHV3-74 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	4.94e-09	185	237	11	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	GLDC IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	5.84e-09	188	237	11	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	5.84e-09	188	237	11	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AARS1 HMMR GLDC ASPM IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.18e-09	189	237	11	73ee4cfb1057832f700be59b6917dedde3e89880
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AARS1 HMMR GLDC ASPM IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.18e-09	189	237	11	c296660061b46e3abae1e7cf29df20274e5a8add
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AARS1 HMMR GLDC ASPM IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.18e-09	189	237	11	f2daf4889ef98bbefe3e44832618ac102a75b4d9
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AARS1 HMMR GLDC ASPM IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.18e-09	189	237	11	31594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AARS1 HMMR GLDC ASPM IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	6.18e-09	189	237	11	9de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	6.89e-09	191	237	11	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	ASPM IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	7.68e-09	193	237	11	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	8.11e-09	194	237	11	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGHV3-72 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7	8.55e-09	195	237	11	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-72 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7	8.55e-09	195	237	11	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-66 IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	9.02e-09	196	237	11	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	9.02e-09	196	237	11	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 TLR10	9.02e-09	196	237	11	e9fe5090452ffdde4bb81b62d57037d823281d00
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 TLR10 GUCY2C	9.02e-09	196	237	11	c2e17f3b2217f20bd7f28a1db4aa7d9a95c52a9c
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 TLR10	9.51e-09	197	237	11	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	COVID_vent-Lymphocytic-Plasma_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	AARS1 GLDC IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7	1.00e-08	198	237	11	e84c5f712e1dea548d0e2aba6625598f9671d3a0
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	PGM2L1 TENM2 RYR2 SERPINI1 NECAB1 YWHAG YWHAZ AKAP9 LMO7 DNM3 DAAM1	1.11e-08	200	237	11	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	PGM2L1 TENM2 RYR2 SERPINI1 NECAB1 YWHAG YWHAZ AKAP9 LMO7 DNM3 DAAM1	1.11e-08	200	237	11	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AARS1 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-38 IGHV3-33 IGHV3-15 IGHV3-11 IGHV3-7	2.33e-08	167	237	10	afb6d0993f3fd44a295874673055189d514f7b11
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLDC IGHV3-74 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	3.26e-08	173	237	10	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11	3.64e-08	175	237	10	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGHV3-64D IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7	3.64e-08	175	237	10	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	GLDC IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	4.05e-08	177	237	10	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ASPM IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-7 TLR10 IGF2BP1	4.05e-08	177	237	10	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	GLDC IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	4.05e-08	177	237	10	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP PIK3C2A PIK3C2B FGD5 TEK ARHGAP5 LMO7 UNC45B LPAR6 DNM3	5.00e-08	181	237	10	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGHV3-64D IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-7 TLR10 GUCY2C	5.55e-08	183	237	10	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGHV3-64D IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-7 TLR10 GUCY2C	5.55e-08	183	237	10	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-64D IGHV3-72 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-11 IGHV3-7 SDR42E2	5.55e-08	183	237	10	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 MYO7B ABCA13 LAMA1 NEB RYR2 PTPRQ DNAH9 MROH2A CNKSR2	5.84e-08	184	237	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 MYO7B ABCA13 LAMA1 NEB RYR2 PTPRQ DNAH9 MROH2A CNKSR2	5.84e-08	184	237	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 MYO7B ABCA13 LAMA1 NEB RYR2 PTPRQ DNAH9 MROH2A CNKSR2	5.84e-08	184	237	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 TLR10	6.47e-08	186	237	10	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	GLDC IGHV3-74 IGHV3-72 IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7	7.51e-08	189	237	10	dceb011216deb4ffd830144a53c635c05dff5ec5
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11	1.01e-07	195	237	10	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 TLR10	1.11e-07	197	237	10	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	AARS1 GLDC IGHV3-72 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7	1.11e-07	197	237	10	fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 TLR10	1.11e-07	197	237	10	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	GLDC IGHV3-66 IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7	1.11e-07	197	237	10	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HMMR ASPM IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7	1.11e-07	197	237	10	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	Tracheal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 KRT7 KRT14 KRT18 UGT1A6 KIF21A LAMC2 TFAP2A KRT23 LMO7	1.28e-07	200	237	10	efd461c687155c84ef590352207e6fe4ba392a90
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm\|6m / Sample Type, Dataset, Time_group, and Cell type.	NEB MYLK4 SRL MYO18B TRIM72 BIN1 ABCC9 DMC1 LMO7 UNC45B	1.28e-07	200	237	10	0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B LAMA1 RYR2 SEMA3A PTPRQ DNAH9 CACNA1B MROH2A RIMBP2	2.03e-07	160	237	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B LAMA1 RYR2 SEMA3A PTPRQ DNAH9 CACNA1B MROH2A RIMBP2	2.03e-07	160	237	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	GLDC IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-11	2.25e-07	162	237	9	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	GLDC IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-11	2.25e-07	162	237	9	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	SERPINI1 IGHV3-72 IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-11 IGHV3-7	3.22e-07	169	237	9	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HMMR GLDC ASPM IGHV3-74 IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-23 IGHV3-11	3.56e-07	171	237	9	13126a3fbee181412c13ffb0c347277b9d8f16f7
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-64D GLDC IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7	3.93e-07	173	237	9	0ca2169a275404118038c0489a48062879488765
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7	4.76e-07	177	237	9	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7	4.76e-07	177	237	9	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasmablasts\|Liver / Manually curated celltypes from each tissue	HMMR IGHV3-64D GLDC ASPM IGHV3-66 IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-7	4.76e-07	177	237	9	1d88ae316d65ca5fdc736c9da93885b6b40c32bb
Computational	Intermediate filaments and MT.	HIP1 KRT7 KRT13 KRT14 NUMA1 LAMC2	1.01e-04	68	119	6	MODULE_438
Computational	Genes in the cancer module 68.	KRT7 KRT13 KRT14 KRT18	1.77e-04	26	119	4	MODULE_68
Computational	Keratin.	KRT7 KRT13 KRT14 KRT18	1.77e-04	26	119	4	MODULE_298
Drug	sulfur mustard	HNMT CNGA1 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 LAMC2 KRT23	4.93e-08	130	217	11	CID000010461
Drug	NSC134723	KRT9 KRT12 KRT14 KRT23	1.19e-07	6	217	4	CID000281830
Drug	homocysteine thiolactone	HNMT DNAH9 KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	5.31e-07	131	217	10	CID000107712
Drug	NSC34533	KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	7.85e-07	54	217	7	CID000003512
Drug	al-Badry	KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 UGT1A6 KRT23 UGT1A1	4.34e-06	165	217	10	CID000004545
Drug	olomoucine II	KRT7 KRT9 KRT13 KRT14 KRT23	5.11e-06	27	217	5	CID005494414
Drug	nocodazole	MYO3A ANAPC1 ZER1 HOOK2 NXF1 KRT18 NUMA1 LAMP1 FSD1 VPS54 BLOC1S2 AKAP9 CENPH ZW10 CEP57 PCNT	1.49e-05	477	217	16	CID000004122
Drug	1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one	PIK3C2A PIK3C2B PIK3C3 PI4KA PRKDC	1.67e-05	34	217	5	ctd:C569670
Drug	R-Te	DNAH9 NXF1 KRT13 KRT14 KRT18 DYNC2H1	1.69e-05	57	217	6	CID000068913
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	HIP1 TTLL5 NEB SMG7 ZER1 CNGA1 TBC1D30 LAMC2 LMO7 ZW10	1.88e-05	195	217	10	6648_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	TTLL5 HNMT ALMS1 KRT13 DYNC2H1 NUMA1 FSD1 YWHAZ ELMO2 GABPB1	1.97e-05	196	217	10	7022_DN
Drug	Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A	RALGAPA1 RXYLT1 SMG7 ALMS1 AP2A2 IQCG TBC1D30 NUMA1 LAMP1 MED1	1.97e-05	196	217	10	6692_DN
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A	RALGAPA1 LARP6 TTLL5 RASAL2 KRT9 BIN1 A1CF CALB2 LAMC2 RASSF8	2.34e-05	200	217	10	4377_DN
Drug	teleocidin B	KRT7 KRT9 KRT12 KRT13 KRT14 KRT18 KRT34 KRT23	2.41e-05	123	217	8	CID000072425
Drug	K 34	KRT12 KRT14 KRT23	2.91e-05	7	217	3	CID000281833
Disease	fibroblast growth factor 8 isoform A measurement	IGHV3-64D IGHV3-7	5.58e-05	2	221	2	EFO_0020385
Disease	insomnia, bilirubin measurement	UGT1A6 MROH2A UGT1A1	6.54e-05	11	221	3	EFO_0004570, EFO_0004698
Disease	Squamous cell carcinoma of lung	ATR MYLK4 MYO18B PRKDC	9.34e-05	32	221	4	C0149782
Disease	tumor necrosis factor ligand superfamily member 11 measurement	IGHV3-21 IGHV3-11 IGHV3-7	1.12e-04	13	221	3	EFO_0010617
Disease	Saldino-Noonan Syndrome	DYNC2H1 C2CD3 TTC21B	1.42e-04	14	221	3	C0036069
Disease	dynein light chain 1, cytoplasmic measurement	IGHV3-64D IGHV3-7	1.67e-04	3	221	2	EFO_0020339
Disease	Seckel syndrome 1	ATR PCNT	1.67e-04	3	221	2	C4551474
Disease	West Nile fever (is_implicated_in)	CCR5 RFC1	1.67e-04	3	221	2	DOID:2366 (is_implicated_in)
Disease	intellectual disability (implicated_via_orthology)	NSUN2 YWHAQ RB1 UBR4 YWHAZ	2.54e-04	75	221	5	DOID:1059 (implicated_via_orthology)
Disease	Polydactyly	ALMS1 DYNC2H1 CEP290 TFAP2A C2CD3 TTC21B	2.58e-04	117	221	6	C0152427
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	3.32e-04	4	221	2	cv:C0265275
Disease	arthrogryposis multiplex congenita (is_implicated_in)	VPS33B SYNE1	3.32e-04	4	221	2	DOID:0080954 (is_implicated_in)
Disease	Malignant neoplasm of breast	TRERF1 HMMR SEMA3A FGD5 DNAH9 RASAL2 KRT14 KRT18 RB1 DYNC2H1 SYNE1 UBR4 ELP1 TEK TFAP2A AKAP9 TRAPPC12 UNC45B ANKRD30A	4.98e-04	1074	221	19	C0006142
Disease	Cerebellar Ataxia	SYNE1 RFC1	5.50e-04	5	221	2	C0007758
Disease	Woolly hair, congenital	KRT25 LPAR6	5.50e-04	5	221	2	C0345427
Disease	Ovarian Serous Adenocarcinoma	LRRK2 MYO3A TEK	6.57e-04	23	221	3	C1335177
Disease	Small cell carcinoma of lung	MYO18B RB1 KIF21A RASSF8	7.22e-04	54	221	4	C0149925
Disease	kidney disease (is_implicated_in)	VPS33B CEP290	8.21e-04	6	221	2	DOID:557 (is_implicated_in)
Disease	response to antipsychotic drug	CNTNAP5 DYNC2H1 RNASE10 CDK5RAP2	1.08e-03	60	221	4	GO_0097332
Disease	Wooly hair	KRT25 LPAR6	1.14e-03	7	221	2	C0343073
Disease	preterm premature rupture of the membranes, spontaneous preterm birth	LGR4 CNKSR2 TTC21B	1.18e-03	28	221	3	EFO_0006917, MONDO_0012511
Disease	Myopathies, Nemaline	NEB KLHL9	1.52e-03	8	221	2	C0206157
Disease	microcephaly (is_implicated_in)	ASPM CDK5RAP2	1.52e-03	8	221	2	DOID:10907 (is_implicated_in)
Disease	microcephaly (implicated_via_orthology)	AARS1 ASPM CDK5RAP2	1.75e-03	32	221	3	DOID:10907 (implicated_via_orthology)
Disease	X-11442 measurement	UGT1A6 UGT1A1	1.94e-03	9	221	2	EFO_0021236
Disease	X-11441 measurement	UGT1A6 UGT1A1	1.94e-03	9	221	2	EFO_0021235
Disease	nephronophthisis (implicated_via_orthology)	TTC21A TTC21B	1.94e-03	9	221	2	DOID:12712 (implicated_via_orthology)
Disease	circulating cell free DNA measurement	UGT1A6 UGT1A1	1.94e-03	9	221	2	EFO_0004739
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A6 UGT1A1	1.94e-03	9	221	2	EFO_0004570, GO_0009410
Disease	Carcinoma, Small Cell	RB1 UGT1A1	1.94e-03	9	221	2	C0262584
Disease	cystic kidney disease (implicated_via_orthology)	CEP290 TTC21B	2.42e-03	10	221	2	DOID:2975 (implicated_via_orthology)
Disease	theophylline measurement	LRRK2 YWHAG	2.42e-03	10	221	2	EFO_0021180
Disease	bilirubin measurement, response to tenofovir	UGT1A6 UGT1A1	2.42e-03	10	221	2	EFO_0004570, EFO_0009279
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A6 UGT1A1	2.42e-03	10	221	2	EFO_0802185
Disease	Colorectal Carcinoma	ABCA13 LAMA1 ABCC8 ABCD2 RASAL2 SYNE1 CNKSR2 TNNI3K AKAP9 GUCY2C LMO7 CENPH GABPB1	2.59e-03	702	221	13	C0009402
Disease	hepatitis B (is_implicated_in)	CCR5 UGT1A6 UGT1A1	2.67e-03	37	221	3	DOID:2043 (is_implicated_in)
Disease	unipolar depression, alcohol dependence	NEB SEMA3A RB1 LPAR6	2.83e-03	78	221	4	EFO_0003761, MONDO_0007079
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	2.94e-03	11	221	2	C0265275
Disease	Tachycardia, Ventricular	RYR2 ABCC9	2.94e-03	11	221	2	C0042514
Disease	histidine betaine (hercynine) measurement	UGT1A6 UGT1A1	2.94e-03	11	221	2	EFO_0800972
Disease	X-21796 measurement	UGT1A6 UGT1A1	2.94e-03	11	221	2	EFO_0800825
Disease	aldosterone measurement	UGT1A6 UGT1A1	2.94e-03	11	221	2	EFO_0010219
Disease	Global developmental delay	CACNA1B PIGB AGO1 SLC25A12 TRAPPC12	3.33e-03	133	221	5	C0557874
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	HOOK2 SYNE1	3.51e-03	12	221	2	DOID:11726 (implicated_via_orthology)
Disease	biliverdin measurement	UGT1A6 UGT1A1	3.51e-03	12	221	2	EFO_0021033
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 TTC21B	4.13e-03	13	221	2	C0036996
Disease	Bardet-Biedl Syndrome	ALMS1 CEP290	4.13e-03	13	221	2	C0752166
Disease	caudate volume change measurement	AARS1 CNKSR2	4.79e-03	14	221	2	EFO_0021491
Disease	Majewski Syndrome	DYNC2H1 TTC21B	4.79e-03	14	221	2	C0024507
Disease	familial atrial fibrillation (is_implicated_in)	ABCC9 NUP155	4.79e-03	14	221	2	DOID:0050650 (is_implicated_in)
Disease	myocardial infarction	DAB2IP CCM2 VPS33B FGD5 DYNC2H1 HECTD4 IGF2BP1 GPSM1	5.09e-03	350	221	8	EFO_0000612
Disease	Osteosarcoma	RB1 RFC1 ZW10	5.27e-03	47	221	3	C0029463
Disease	serum metabolite measurement	RALGAPA1 NCAPH2 CHMP7 ALMS1 ERAP2 YWHAQ IGHV3-49 IGHV3-48 UGT1A6 TEK TFAP2A UGT1A1 LRPPRC CACNG5 PHLPP2	5.29e-03	945	221	15	EFO_0005653
Disease	Generalized hypotonia	PIGB AGO1	5.50e-03	15	221	2	C1858120
Disease	Autosomal recessive primary microcephaly	ASPM CDK5RAP2	5.50e-03	15	221	2	cv:C3711387
Disease	alcohol consumption measurement	PRSS3 TENM2 CNTNAP5 ALMS1 HACE1 LAMC2 RFC1 MED1 RGS3 DMC1 LRPPRC IGF2BP1 AKAP9 CSTF3 CDK5RAP2 NOSTRIN ZW10 PHLPP2	5.96e-03	1242	221	18	EFO_0007878
Disease	focal segmental glomerulosclerosis	CCDC30 ALMS1	6.25e-03	16	221	2	EFO_0004236
Disease	Keratoderma, Palmoplantar	KRT9 KRT14	6.25e-03	16	221	2	C4551675
Disease	Mammary Carcinoma, Human	TRERF1 HMMR FGD5 KRT14 KRT18 RB1 DYNC2H1 SYNE1 ELP1 TFAP2A	6.52e-03	525	221	10	C4704874
Disease	Mammary Neoplasms, Human	TRERF1 HMMR FGD5 KRT14 KRT18 RB1 DYNC2H1 SYNE1 ELP1 TFAP2A	6.52e-03	525	221	10	C1257931
Disease	Mammary Neoplasms	TRERF1 HMMR FGD5 KRT14 KRT18 RB1 DYNC2H1 SYNE1 ELP1 TFAP2A	6.68e-03	527	221	10	C1458155
Disease	asthma (is_implicated_in)	HNMT CLCA1 CCR5 ELP1 TLR10	6.70e-03	157	221	5	DOID:2841 (is_implicated_in)
Disease	Muscle hypotonia	RALGAPA1 PAX7	7.05e-03	17	221	2	C0026827
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	IGFN1 SRBD1	7.05e-03	17	221	2	EFO_0010543, EFO_0010544
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A6 UGT1A1	7.05e-03	17	221	2	EFO_0004611, EFO_0007800
Disease	Alzheimer disease, psychotic symptoms	BIN1 RIMBP2	7.05e-03	17	221	2	EFO_0005940, MONDO_0004975

Protein segments in the cluster

Peptide	Gene	Start	Entry
SEVLEYMNQLSASLK	TDRD1	286	Q9BXT4
QQLLERKPDNYMTLS	TTC21B	976	Q7Z4L5
LTATSEDYKLLENMN	BLOC1S2	56	Q6QNY1
LNEDSYKDSTLIMQL	YWHAG	211	P61981
YKDSTLIMQLLRDNL	YWHAG	216	P61981
LNEDSYKDSTLIMQL	YWHAQ	206	P27348
YKDSTLIMQLLRDNL	YWHAQ	211	P27348
RDAYENLTAKVLAML	B3GALT6	126	Q96L58
TEKYKLDSLQTRQQM	AKAP9	3366	Q99996
MLNDTKRNTIYNAAI	PRMT9	156	Q6P2P2
MLTNLESLSLDRIYN	ANAPC2	761	Q9UJX6
LDYISTSKQMDLLQE	COPS2	116	P61201
IRMNKKDLASLNYIS	CRYBG3	581	Q68DQ2
KILYVRNLMLSTSEE	A1CF	231	Q9NQ94
KSYKALADQMNLILS	ABCD2	321	Q9UBJ2
LNEDSYKDSTLIMQL	YWHAH	211	Q04917
YKDSTLIMQLLRDNL	YWHAH	216	Q04917
KYLSVQDRMELAASL	BARHL1	201	Q9BZE3
EISRLMKNASYNLDP	AGO1	376	Q9UL18
ETLRQYQAAKSVMRS	ALMS1	2376	Q8TCU4
LQRKMNVDVSSTIYN	ANKRD30A	1231	Q9BXX3
LLEQEYNKLTTMQAL	CEP57	191	Q86XR8
TALQNYLTEALKAMD	TFAP2A	396	P05549
IDNENISMARKLLAY	ANKRD62	146	A6NC57
ILSYMNQSKDFSDIL	ABCA13	2621	Q86UQ4
QRMLELTDTNNIAYL	ABCC9	1196	O60706
DYMLTLRTKLSSQEI	CCM2	301	Q9BSQ5
LKSMTDIYLLNLAIS	CCR5	61	P51681
LAQMLSRLQKISEEY	DMC1	246	Q14565
ENKDLRYKLIMNQTS	CCDC74B	81	Q96LY2
KQSIAQRARTMALYN	CACNA1B	46	Q00975
KQDQQRYEMLKSSTL	ASPM	1411	Q8IZT6
LRKMQTAATLIQSNY	ASPM	2186	Q8IZT6
RDRLATSQMNKFLYL	ATG2B	1651	Q96BY7
LSVMNIVAKLYRDSS	ADAMTS6	276	Q9UKP5
LQAQMYRLTLRTSKE	AP2A2	911	O94973
AMENRYKSLLSESNK	CDK5RAP2	456	Q96SN8
NVRENLKTLYRLTMD	POLN	396	Q7Z5Q5
KSNLENRYMKTNTEL	IQCG	261	Q9H095
MQRLKTNILQYASTR	RB1	761	P06400
NKLKDYLAQIRTMES	RASSF8	256	Q8NHQ8
DLYRMNSQDKLGLTV	PDZRN3	421	Q9UPQ7
YNAVLDLVNNKMRIS	QSOX2	391	Q6ZRP7
RSDLYLDLINQKKMS	RGS3	1181	P49796
KNESYMDTLIRRLQL	GUCY2C	756	P25092
DYLAKNVSLSTQRRM	PAX7	471	P23759
KMNITYDNLRVLGNT	LTN1	1056	O94822
YMVSKELRNVLLNNS	NSUN2	561	Q08J23
LAMIYLKTNNRSIAD	ANAPC1	1371	Q9H1A4
ARLMSALTQLKERYS	DAB2IP	1146	Q5VWQ8
ALTQLKERYSMQARN	DAB2IP	1151	Q5VWQ8
AMSKTLRDFLYAQQV	PADI6	451	Q6TGC4
NSLIYSLRNKDMKEA	OR2B3	286	O76000
TLYLQMNSLRAEDTA	IGHV3-66	96	A0A0C4DH42
ISRDDSKNSLYLQMN	IGHV3-72	91	A0A0B4J1Y9
KETMQSLNDRLASYL	KRT18	81	P05783
NSLYLQMNSLRAEDT	IGHV3-11	96	P01762
NSLYLQMNSLRAEDT	IGHV3-43D	96	P0DP04
NTLYLQMNSLRAEDT	IGHV3-30-5	96	P0DP03
KVVLQSRDYNALSMS	MADD	321	Q8WXG6
MEQIKRANRLYTNDS	LYSMD1	61	Q96S90
KETMQNLNDRLASYL	KRT12	126	Q99456
ISRDDSKNTLYLQMN	IGHV3-15	91	A0A0B4J1V0
IDYMNRKLDFTLSAN	MGAM2	1236	Q2M2H8
LAKLNAMNISETRYK	NRAP	1016	Q86VF7
SREKALLMASQAYLE	GPR179	846	Q6PRD1
TMQELNSRLASYLDK	KRT9	156	P35527
QLREYQELMSVKLAL	KRT7	371	P08729
TKMYRAVLDATQRQL	MYO1A	981	Q9UBC5
NMLIKYQSSRIDDQR	GPSM1	601	Q86YR5
NSLYLQMNSLRAEDT	IGHV3-7	96	P01780
NTLYLQMNSLRAEDT	IGHV3-30-3	96	P0DP02
KVTMQNLNDRLASYL	KRT14	116	P02533
QLSAEIMDYQSRLKN	FYCO1	1006	Q9BQS8
IYSLKQMLLNVEANS	FSD1	26	Q9BTV5
NLKMVLRSLVEYSQD	HOOK2	71	Q96ED9
LRKISSIANSFLYMQ	IL19	101	Q9UHD0
SIANSFLYMQKTLRQ	IL19	106	Q9UHD0
YSNREQTRQAIMKLN	IGF2BP1	126	Q9NZI8
TISRDNSKNTLYLQM	IGHV3-38	86	A0A0C4DH36
LKVLSSELNMYEVQS	CFAP58	791	Q5T655
NSLYLQMNSLRAEDT	IGHV3-9	96	P01782
SRVLNKNYTLLVSMA	FAM91A1	491	Q658Y4
EAYRQKLEAMTRLQT	GABPB1	376	Q06547
ITMQNLNDRLASYLE	KRT13	106	P13646
TIRNLVDSYMSIINK	DNM3	661	Q9UQ16
LLAQLYSSEDQNTLM	DNM3	701	Q9UQ16
NSLYLQMNSLRAEDT	IGHV3-48	96	P01763
LLRQESELMYKSKAQ	MICALL2	791	Q8IY33
SDDLTQMLDNLGLKY	HNMT	201	P50135
QLKLIMSKRYDGSQQ	NXF1	211	Q9UBU9
RLYRLDDMSSIVQKA	NXF1	276	Q9UBU9
VIYSLRNDSMKAALR	OR14J1	286	Q9UGF5
AKRKIELNSYLQSLM	PIK3C2A	1501	O00443
ASYLETMNITLKQQL	PGM2L1	461	Q6PCE3
YSDLMQLLKQSILAT	PDE11A	761	Q9HCR9
NIYERAISTLLKKNM	CSTF3	326	Q12996
YRLKNTLAVANMKVS	FGD5	1151	Q6ZNL6
NYKLMELNLEIRESL	FRYL	2976	O94915
ADILELSVKYMRSLQ	HES3	36	Q5TGS1
SNYDAQMKSLLRIVR	HACE1	311	Q8IYU2
SYNLTELDTILFMKQ	MYLK4	196	Q86YV6
LRSVLQYNSAMKNDT	PI4KA	841	P42356
NTRLMSALTQVKERY	RASAL2	1096	Q9UJF2
YTAKLSLNMDNLQDT	KLHL9	111	Q9P2J3
MQNLNDRLASYLEKV	KRT23	76	Q9C075
VTMQNLNDRLASYLE	KRT27	86	Q7Z3Y8
VTMQNLNDRLASYLD	KRT25	81	Q7Z3Z0
NSKYLDEELMVLSSN	LMO7	1271	Q8WWI1
ENKDYMILLSALTNF	LRRK2	201	Q5S007
LNKSLNKRVEELQYM	LARP6	316	Q9BRS8
NAETYSNLIKLLMSE	LRPPRC	1066	P42704
SNLIKLLMSEDYFTQ	LRPPRC	1071	P42704
EQKMLRTLDLSYNNI	LGR4	341	Q9BXB1
LNTLKKMETNYQRFT	ELP1	921	O95163
NSLYLQMNSLRAEDT	IGHV3-20	96	A0A0C4DH32
RDNSKNTLYLQMSSL	IGHV3-64D	91	A0A0J9YX35
LKVRNETTTYMINLA	LPAR6	46	P43657
NTLYLQMNSLRAEDT	IGHV3-74	96	A0A0B4J1X5
RKEMQLYNSIFSLLS	CYHR1	211	Q6ZMK1
LITQRISAAMYKSLD	CYFIP2	791	Q96F07
AKSINEMLLSRLSRY	HECTD4	76	Q9Y4D8
ISRDDSKSIAYLQMN	IGHV3-49	91	A0A0A0MS15
NSLYLQMNSLRAEDT	IGHV3-21	96	A0A0B4J1V1
KLNRLLYSMTFQNVD	PCNT	2076	O95613
NQSLTSDYKRLVMQF	DRC1	366	Q96MC2
MLRESLKEYQKISNQ	NUP155	896	O75694
LYMKNTSTTDIILRN	PTPRQ	751	Q9UMZ3
TRLNLKSTYDAEMLR	PIK3C2B	236	O00750
QEYVRMLLDLQTKSA	HMMR	506	O75330
NKYRSSETKRINIML	NPY1R	251	P25929
LEAEKQMLSALNYKR	PARP14	586	Q460N5
FLLQSRMANADLVKY	FBXO38	361	Q6PIJ6
AMESSVLRVRLYNNK	MALRD1	356	Q5VYJ5
YIDQLNSMAARKSLL	DAAM1	106	Q9Y4D1
ISDLSKINNMYRFSL	DYNC2H1	3506	Q8NCM8
ALLSLNKRPDYNEMV	ATR	1906	Q13535
LYISSINDEMLNRTK	CACNG5	151	Q9UF02
LSSKYLERLKNNVMV	C2CD3	866	Q4AC94
RRLFESINNLMKSQY	DOCK2	771	Q92608
LRAQTKQQLLEYKSM	CENPH	46	Q9H3R5
ILESMVLNSQSLYQK	ELMO2	196	Q96JJ3
SKLQKMEAYNLRLEQ	CEP290	1226	O15078
VYQLMQSEQLLSRKV	CHMP7	241	Q8WUX9
YLLSLSQRDTMLKEL	GCC2	571	Q8IWJ2
ISSIQSRVLYMDKEN	CCDC30	586	Q5VVM6
LSQKEYSDLLNTQDM	APBA1	626	Q02410
NTLYLQMNSLRAEDT	IGHV3-23	96	P01764
NTLYLQMNSLRAEDT	IGHV3-30	96	P01768
LSKDLYLISQMDSDQ	LARP4	136	Q71RC2
QYELSMSSAEQNKIL	ERAP2	811	Q6P179
VYQKAAMRSAINILL	GPR63	106	Q9BZJ6
SQENSYQSRLDDLKM	LAMC2	686	Q13753
MGLQLNLTYERKDNT	LAMP1	236	P11279
NIQQLTNYRKSVMSL	CALB2	236	P22676
EDKMAQYINTISSLR	IGFN1	206	Q86VF2
YSRTKAIADQLTLMA	SDR42E2	176	A6NKP2
RDTSDKYLVLIQMFN	DNAH9	561	Q9NYC9
QKLVDQALLTMDTYL	BIN1	116	O00499
STQLLKRTQAMLNKY	BICRA	1141	Q9NZM4
YRRSQISMEQLEKLQ	CA14	231	Q9ULX7
NLRYMKESQVLLTLT	DCTN4	316	Q9UJW0
IYENSSRQALMNILK	RXYLT1	276	Q9Y2B1
YNLQMSLETLKTLLA	RYR2	931	Q92736
RSSLLYRFNQKLMST	CNTNAP5	186	Q8WYK1
TKMYLALQSLEQDLS	MED1	171	Q15648
EAIKNLQMLTYLNIS	LRCH2	151	Q5VUJ6
NLLIYSLRNSEMKRA	OR10A6	286	Q8NH74
LRAEKASYAEQLSML	NUMA1	1426	Q14980
NTLYLQMNSLRAEDT	IGHV3-33	96	P01772
TLYLQMNSLRAEDTA	IGHV3-53	96	P01767
IADLSVNMYNRLRAT	SERPINI1	26	Q99574
LDLLEANSYKLSSML	NOSTRIN	356	Q8IVI9
ANSYKLSSMLAELEQ	NOSTRIN	361	Q8IVI9
SNYETFTLLIEQLKM	POTEA	436	Q6S8J7
TLYANALSSLEQLME	MROH2A	921	A6NES4
LETMAYVKNNLSRIR	MROH2A	1591	A6NES4
SAVADVRLYSLMKQL	PIGB	151	Q92521
VSAMEKQYLRNSNLT	MEIOC	201	A2RUB1
IEMDLKSRTAAYNTL	ATP6V1C2	131	Q8NEY4
SYNVLVDKETRMNLT	RIMBP2	331	O15034
QMARKVKQYLSSLDV	RAPGEF6	1106	Q8TEU7
YEMQRNLSLENAKTS	TLR10	231	Q9BXR5
DLMREYQNLKSAVSK	SYNE1	2086	Q8NF91
KRTMLSEVLQYIQDS	TADA2A	316	O75478
TMQFLNDRLASYLEK	KRT34	101	O76011
LYMKRNSLTSLPENL	LRRC28	46	Q86X40
LAVKSFRMQNTLYLS	LGI2	421	Q8N0V4
KRTVNMDYLSLLRDA	RFC1	991	P35251
VAEVSRYLSQMKNLR	PRAMEF19	221	Q5SWL8
NSAKMALYRLESVSL	LAMA1	676	P25391
RYSNLILNLFSLMVD	PIK3C3	811	Q8NEB9
TSRQALQDLYQKMLV	SMG7	31	Q92540
LKDSLRYRNELSDMS	HIP1	111	O00291
YLDKSMVLLLQSQRQ	TENM2	1936	Q9NT68
LLFSQMYDKLSENSV	VPS8	596	Q8N3P4
MASLLAKDAYLQSLA	SURF6	1	O75683
KKNMIENSYLSDNTR	ARHGAP5	941	Q13017
RLKLSYKEMLESNNV	SEMA3A	31	Q14563
VKMYRSKNDLSQLQL	SFR1	176	Q86XK3
LMKILYNSLNDSFKR	SRBD1	481	Q8N5C6
YSNERLKQTNEMLRG	ABCC8	491	Q09428
YKDSTLIMQLLRDNL	YWHAZ	211	P63104
LNNMELVRKIYSTLA	SLC25A12	226	O75746
ILTKSYMELLQRNES	CIP2A	726	Q8TCG1
QQIKDMVTQASLYLL	CLCA1	51	A8K7I4
RSMLASLQLANDYTV	NCAPH2	551	Q6IBW4
LAEYESMQQKLKQRL	CNGA1	641	P29973
NSLLRYMSNEKIAQE	CNKSR2	466	Q8WXI2
RSNIVDMLYLKDLAF	CNNM3	356	Q8NE01
LINTSRNYSIMKFNE	ZNF37A	81	P17032
NYEILTMLLKQDVSL	TRPC1	171	P48995
TRMLASILINKLYDD	UNC45B	351	Q8IWX7
LYRDVMQETFKNLTS	ZNF20	31	P17024
KDSLVSLVLYNMDLS	ZER1	221	Q7Z7L7
NYRNLEAVDISSKRM	ZNF578	56	Q96N58
VRLSLQYEEAKRSMA	WWC2	306	Q6AWC2
METLTKVLARNLYSL	RALGAPA1	666	Q6GYQ0
MANKELKQLRASYTE	TCEANC	261	Q8N8B7
YTLRNEEMKSALNKL	OR4E1	291	P0C645
MLRASALFQSNKDYL	RNASE10	96	Q5GAN6
RLVSVLQNKMSNYDT	AARS1	246	P49588
EESLSMLQLLYLTNN	PHLPP2	616	Q6ZVD8
AIYDLLDTAMINNSR	PIGT	316	Q969N2
YELESSRSMQKKQAL	TRAPPC12	701	Q8WVT3
METLNTLKYANRARN	KIF21A	356	Q7Z4S6
KSTMINYLLGLENTR	SRL	106	Q86TD4
INDKSYKENIMRLSS	UGT1A1	431	P22309
ERMTTDINALKRQYS	TBC1D30	631	Q9Y2I9
SLNSYLEQLRQMEKV	TRIM72	211	Q6ZMU5
SLNRMLEERKTYVNT	TEK	1091	Q02763
LVAENLATYMNSIRL	USP9Y	616	O00507
TDNKVMLELAQLYLL	TTC21A	921	Q8NDW8
MTRNKSLVDEQLYRL	MYO18B	1871	Q8IUG5
LLNTMSQEEKAAYLS	PRKDC	3816	P78527
YNRDTLDNDIMLIKL	PRSS3	156	P35030
MLQEYSKFLQQALDR	ZNF148	601	Q9UQR1
NDKSYKENIMRLSSL	UGT1A6	431	P19224
MNLLLTLLSTSYRKA	UBR4	531	Q5T4S7
QGLSLEEMKRSLQYT	TNNI3K	791	Q59H18
SNDSNINLKRMSVYV	TERB1	111	Q8NA31
NMRYIASLVNADKLA	VPS33B	91	Q9H267
LSKMQARIAFSAYLQ	TTLL5	671	Q6EMB2
SKRYNQSMVTAELQR	TTLL5	1021	Q6EMB2
LQDYLRKTSQAVKML	VPS54	241	Q9P1Q0
LLDSSQKNLYREVMQ	ZNF669	106	Q96BR6
SLSMELTIQKQNILY	ZW10	161	O43264
QLKTYSSDRQAQAML	TRERF1	406	Q96PN7
LKQATETAILNANYM	GLDC	826	P23378
NYQMRTSEKLINLAK	MYO3A	891	Q8NEV4
KMDDLLTSYVQQLLS	MYO7B	2086	Q6PIF6
LSRVNQITMSDKLYK	NEB	1771	P20929
IMLARQNKINYSETL	NEB	2986	P20929
EIMLAKLNRINYSDK	NEB	3471	P20929
LRISIQKLSNESRYM	NECAB1	286	Q8N987